{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T21:00:03Z","timestamp":1793826003545,"version":"4.6.1"},"reference-count":340,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T00:00:00Z","timestamp":1752796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T00:00:00Z","timestamp":1752796800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004543","name":"China Scholarship Council","doi-asserted-by":"publisher","award":["202310100030"],"award-info":[{"award-number":["202310100030"]}],"id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 62401300"],"award-info":[{"award-number":["No. 62401300"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004763","name":"Natural Science Foundation of Inner Mongolia Autonomous Region","doi-asserted-by":"publisher","award":["No. 2022LHQN03005"],"award-info":[{"award-number":["No. 2022LHQN03005"]}],"id":[{"id":"10.13039\/501100004763","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clinic Rev Allerg Immunol"],"DOI":"10.1007\/s12016-025-09078-7","type":"journal-article","created":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T16:41:15Z","timestamp":1752856875000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Neurological Complications in Inborn Errors of Immunity: A Scoping Review of Clinical Spectrum, Pathophysiological Mechanisms, and Therapeutic Strategies"],"prefix":"10.1007","volume":"68","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0615-3222","authenticated-orcid":false,"given":"Ningkun","family":"Xiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinlin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linzi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanli","family":"Zang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maosen","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianjiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Tuzankina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valery","family":"Chereshnev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guojun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,18]]},"reference":[{"issue":"1","key":"9078_CR1","doi-asserted-by":"publisher","first-page":"e20250003","DOI":"10.70962\/jhi.20250003","volume":"1","author":"MC Poli","year":"2025","unstructured":"Poli MC, Aksentijevich I, Bousfiha A, Cunningham-Rundles C, Hambleton S, Klein C, Morio T, Picard C, Puel A, Rezaei N (2025) Human inborn errors of immunity: 2024 update on the classification from the international union of immunological societies expert committee. J Hum Immunol 1(1):e20250003","journal-title":"J Hum Immunol"},{"issue":"3","key":"9078_CR2","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/s41576-023-00656-z","volume":"25","author":"YT Akalu","year":"2024","unstructured":"Akalu YT, Bogunovic D (2024) Inborn errors of immunity: an expanding universe of disease and genetic architecture. Nat Rev Genet 25(3):184\u2013195","journal-title":"Nat Rev Genet"},{"issue":"5","key":"9078_CR3","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1038\/s41423-020-00626-z","volume":"18","author":"G Sogkas","year":"2021","unstructured":"Sogkas G, Atschekzei F, Adriawan IR, Dubrowinskaja N, Witte T, Schmidt RE (2021) Cellular and molecular mechanisms breaking immune tolerance in inborn errors of immunity. Cell Mol Immunol 18(5):1122\u20131140","journal-title":"Cell Mol Immunol"},{"key":"9078_CR4","doi-asserted-by":"publisher","first-page":"1371124","DOI":"10.3389\/fimmu.2024.1371124","volume":"15","author":"N Xiao","year":"2024","unstructured":"Xiao N, Huang X, Zang W, Kiselev S, Bolkov MA, Tuzankina IA, Chereshnev VA (2024) Health-related quality of life in patients with inborn errors of immunity: a bibliometric analysis. Front Immunol 15:1371124","journal-title":"Front Immunol"},{"key":"9078_CR5","doi-asserted-by":"publisher","first-page":"108079","DOI":"10.1016\/j.ypmed.2024.108079","volume":"186","author":"N Xiao","year":"2024","unstructured":"Xiao N, Huang X, Yang D, Zang W, Kiselev S, Bolkov MA, Shinwari K, Tuzankina I, Chereshnev V (2024) Health-related quality of life in patients with inborn errors of immunity: a systematic review and meta-analysis. Prev Med 186:108079. https:\/\/doi.org\/10.1016\/j.ypmed.2024.108079","journal-title":"Prev Med"},{"issue":"6","key":"9078_CR6","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1097\/ACI.0000000000001036","volume":"24","author":"D Kurup","year":"2024","unstructured":"Kurup D, FitzPatrick AM, Badura A, Serra I (2024) Bridging the gap: neurodevelopmental disorder risks in inborn errors of immunity. Curr Opin Allergy Clin Immunol 24(6):472\u2013478","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"7","key":"9078_CR7","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1038\/s41577-020-00487-7","volume":"21","author":"KE Zengeler","year":"2021","unstructured":"Zengeler KE, Lukens JR (2021) Innate immunity at the crossroads of healthy brain maturation and neurodevelopmental disorders. Nat Rev Immunol 21(7):454\u2013468","journal-title":"Nat Rev Immunol"},{"key":"9078_CR8","doi-asserted-by":"publisher","unstructured":"Serra I, de Koning M, van der Spek PJ, Dalm VA, Badura A (2025) Analysis of genetic overlap between inborn errors of immunity and neurodevelopmental disorders. medRxiv 2025.03.01.25323148.\u00a0https:\/\/doi.org\/10.1101\/2025.03.01.25323148","DOI":"10.1101\/2025.03.01.25323148"},{"issue":"7","key":"9078_CR9","doi-asserted-by":"publisher","first-page":"467","DOI":"10.7326\/M18-0850","volume":"169","author":"AC Tricco","year":"2018","unstructured":"Tricco AC, Lillie E, Zarin W, O\u2019Brien KK, Colquhoun H, Levac D, Moher D, Peters MD, Horsley T, Weeks L (2018) PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med 169(7):467\u2013473","journal-title":"Ann Intern Med"},{"issue":"12","key":"9078_CR10","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1016\/j.jclinepi.2014.03.013","volume":"67","author":"HL Colquhoun","year":"2014","unstructured":"Colquhoun HL, Levac D, O\u2019Brien KK, Straus S, Tricco AC, Perrier L, Kastner M, Moher D (2014) Scoping reviews: time for clarity in definition, methods, and reporting. J Clin Epidemiol 67(12):1291\u20131294","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"9078_CR11","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.clim.2008.11.002","volume":"131","author":"LR Shiow","year":"2009","unstructured":"Shiow LR, Paris K, Akana MC, Cyster JG, Sorensen RU, Puck JM (2009) Severe combined immunodeficiency (SCID) and attention deficit hyperactivity disorder (ADHD) associated with a Coronin-1A mutation and a chromosome 16p11. 2 deletion. Clin Immunol 131(1):24\u201330","journal-title":"Clin Immunol"},{"issue":"1","key":"9078_CR12","doi-asserted-by":"publisher","first-page":"40136","DOI":"10.1038\/srep40136","volume":"7","author":"AV Sauer","year":"2017","unstructured":"Sauer AV, Hernandez RJ, Fumagalli F, Bianchi V, Poliani PL, Dallatomasina C, Riboni E, Politi LS, Tabucchi A, Carlucci F (2017) Alterations in the brain adenosine metabolism cause behavioral and neurological impairment in ADA-deficient mice and patients. Sci Rep 7(1):40136","journal-title":"Sci Rep"},{"issue":"1","key":"9078_CR13","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1067\/mpd.2001.115023","volume":"139","author":"MH Rogers","year":"2001","unstructured":"Rogers MH, Lwin R, Fairbanks L, Gerritsen B, Gaspar HB (2001) Cognitive and behavioral abnormalities in adenosine deaminase deficient severe combined immunodeficiency. J Pediatr 139(1):44\u201350","journal-title":"J Pediatr"},{"issue":"8","key":"9078_CR14","doi-asserted-by":"publisher","first-page":"3595","DOI":"10.1182\/blood-2006-07-034678","volume":"109","author":"M H\u00f6nig","year":"2007","unstructured":"H\u00f6nig M, Albert MH, Schulz A, Sparber-Sauer M, Sch\u00fctz C, Belohradsky B, G\u00fcng\u00f6r T, Rojewski MT, Bode H, Pannicke U (2007) Patients with adenosine deaminase deficiency surviving after hematopoietic stem cell transplantation are at high risk of CNS complications. Blood 109(8):3595\u20133602","journal-title":"Blood"},{"issue":"7","key":"9078_CR15","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1056\/NEJM198008143030706","volume":"303","author":"R Hirschhorn","year":"1980","unstructured":"Hirschhorn R, Papageorgiou PS, Kesarwala HH, Taft LT (1980) Amelioration of neurologic abnormalities after enzyme replacement in adenosine deaminase deficiency. N Engl J Med 303(7):377\u2013380","journal-title":"N Engl J Med"},{"issue":"4","key":"9078_CR16","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/0387-7604(96)00014-9","volume":"18","author":"C Tanaka","year":"1996","unstructured":"Tanaka C, Hara T, Suzaki I, Maegaki Y, Takeshita K (1996) Sensorineural deafness in siblings with adenosine deaminase deficiency. Brain Develop 18(4):304\u2013306","journal-title":"Brain Develop"},{"issue":"1","key":"9078_CR17","first-page":"45","volume":"128","author":"MP Cicalese","year":"2016","unstructured":"Cicalese MP, Ferrua F, Castagnaro L, Pajno R, Barzaghi F, Giannelli S, Dionisio F, Brigida I, Bonopane M, Casiraghi M (2016) Update on the safety and efficacy of retroviral gene therapy for immunodeficiency due to adenosine deaminase deficiency. Blood, J Am Soc Hematol 128(1):45\u201354","journal-title":"Blood, J Am Soc Hematol"},{"key":"9078_CR18","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1007\/s10875-018-0496-9","volume":"38","author":"D Cagdas","year":"2018","unstructured":"Cagdas D, Gur Cetinkaya P, Karaatmaca B, Esenboga S, Tan C, Y\u0131lmaz T, G\u00fcm\u00fc\u015f E, Bar\u0131\u015f S, Ku\u015fkonmaz B, Ozgur TT (2018) ADA deficiency: evaluation of the clinical and laboratory features and the outcome. J Clin Immunol 38:484\u2013493","journal-title":"J Clin Immunol"},{"issue":"2","key":"9078_CR19","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.jpeds.2003.10.055","volume":"144","author":"W Albuquerque","year":"2004","unstructured":"Albuquerque W, Gaspar HB (2004) Bilateral sensorineural deafness in adenosine deaminase-deficient severe combined immunodeficiency. J Pediatr 144(2):278\u2013280","journal-title":"J Pediatr"},{"issue":"3","key":"9078_CR20","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.pediatrneurol.2007.03.011","volume":"37","author":"Y Nofech-Mozes","year":"2007","unstructured":"Nofech-Mozes Y, Blaser SI, Kobayashi J, Grunebaum E, Roifman CM (2007) Neurologic abnormalities in patients with adenosine deaminase deficiency. Pediatr Neurol 37(3):218\u2013221","journal-title":"Pediatr Neurol"},{"issue":"4","key":"9078_CR21","first-page":"383","volume":"37","author":"I Tezcan","year":"1995","unstructured":"Tezcan I, Ersoy F, Ca\u011flar M, Sanal O, Kotilo\u011flu E, Aysun S (1995) A case of adenosine deaminase-negative severe combined immunodeficiency with neurological abnormalities. Turk J Pediatr 37(4):383\u2013389","journal-title":"Turk J Pediatr"},{"issue":"9","key":"9078_CR22","first-page":"3907","volume":"112","author":"P Titman","year":"2008","unstructured":"Titman P, Pink E, Skucek E, O\u2019Hanlon K, Cole TJ, Gaspar J, Xu-Bayford J, Jones A, Thrasher AJ, Davies EG (2008) Cognitive and behavioral abnormalities in children after hematopoietic stem cell transplantation for severe congenital immunodeficiencies. Blood, J Am Soc Hematol 112(9):3907\u20133913","journal-title":"Blood, J Am Soc Hematol"},{"key":"9078_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02959","volume":"9","author":"MJ Recio","year":"2019","unstructured":"Recio MJ, Dominguez-Pinilla N, Perrig MS, Rodriguez Vigil-Iturrate C, Salm\u00f3n-Rodriguez N, Martinez Faci C, Castro-Panete MJ, Blas-Espada J, L\u00f3pez-Nevado M, Ruiz-Garcia R (2019) Extreme phenotypes with identical mutations: two patients with same non-sense NHEJ1 homozygous mutation. Front Immunol 9","journal-title":"Front Immunol"},{"issue":"5","key":"9078_CR24","doi-asserted-by":"publisher","first-page":"E167","DOI":"10.1111\/j.1399-3046.2011.01491.x","volume":"16","author":"D \u00c7a\u011fda\u015f","year":"2012","unstructured":"\u00c7a\u011fda\u015f D, \u00d6zg\u00fcr TT, Asal GT, Revy P, De Villartay JP, van der Burg M, Sanal \u00d6, Tezcan \u0130 (2012) Two SCID cases with Cernunnos-XLF deficiency successfully treated by hematopoietic stem cell transplantation. Pediatr Transplant 16(5):E167\u2013E171","journal-title":"Pediatr Transplant"},{"issue":"4","key":"9078_CR25","first-page":"313","volume":"21","author":"T Turul","year":"2011","unstructured":"Turul T, Tezcan I, Sanal O (2011) Cernunnos deficiency: a case report. J Investig Allergol Clin Immunol 21(4):313\u2013316","journal-title":"J Investig Allergol Clin Immunol"},{"issue":"10","key":"9078_CR26","doi-asserted-by":"publisher","first-page":"4194","DOI":"10.1172\/JCI128903","volume":"129","author":"CD Conde","year":"2019","unstructured":"Conde CD, Petronczki \u00d6Y, Baris S, Willmann KL, Girardi E, Salzer E, Weitzer S, Ardy RC, Krolo A, Ijspeert H (2019) Polymerase \u03b4 deficiency causes syndromic immunodeficiency with replicative stress. J Clin Investig 129(10):4194\u20134206","journal-title":"J Clin Investig"},{"issue":"3","key":"9078_CR27","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1016\/j.jaci.2019.11.016","volume":"145","author":"J Verheijen","year":"2019","unstructured":"Verheijen J, Wong SY, Rowe JH, Raymond K, Stoddard J, Delmonte OM, Bosticardo M, Dobbs K, Niemela J, Calzoni E (2019) Defining a new immune deficiency syndrome: MAN2B2-CDG. J Allergy Clin Immunol 145(3):1008","journal-title":"J Allergy Clin Immunol"},{"issue":"12","key":"9078_CR28","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1038\/s41431-022-01125-7","volume":"31","author":"Q Tian","year":"2023","unstructured":"Tian Q, Shu L, Shu C, Xi H, Ma N, Mao X, Wang H (2023) Compound heterozygous variants in MAN2B2 identified in a Chinese child with congenital disorders of glycosylation. Eur J Hum Genet 31(12):1455\u20131457","journal-title":"Eur J Hum Genet"},{"key":"9078_CR29","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.parkreldis.2018.12.017","volume":"62","author":"M Paucar","year":"2019","unstructured":"Paucar M, Schechtmann G, Taylor AM, Svenningsson P (2019) Variant ataxia-telangiectasia with prominent camptocormia. Parkinsonism Relat Disord 62:253\u2013255","journal-title":"Parkinsonism Relat Disord"},{"key":"9078_CR30","first-page":"bcr2012007246","volume":"2012","author":"N Kumar","year":"2012","unstructured":"Kumar N, Aggarwal P, Dev N (2012) Ataxia telangiectasia: learning from previous mistakes. Case Reports 2012:bcr2012007246","journal-title":"Case Reports"},{"issue":"5","key":"9078_CR31","doi-asserted-by":"publisher","first-page":"315","DOI":"10.3109\/17518423.2011.603368","volume":"14","author":"A Vinck","year":"2011","unstructured":"Vinck A, Verhagen MM, Gerven MV, de Groot IJ, Weemaes CM, Maassen BA, Willemsen MA (2011) Cognitive and speech-language performance in children with ataxia telangiectasia. Dev Neurorehabil 14(5):315\u2013322","journal-title":"Dev Neurorehabil"},{"issue":"3","key":"9078_CR32","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.pediatrneurol.2014.04.027","volume":"51","author":"F Hoche","year":"2014","unstructured":"Hoche F, Frankenberg E, Rambow J, Theis M, Harding JA, Qirshi M, Seidel K, Barbosa-Sicard E, Porto L, Schmahmann JD (2014) Cognitive phenotype in ataxia-telangiectasia. Pediatr Neurol 51(3):297\u2013310","journal-title":"Pediatr Neurol"},{"issue":"2","key":"9078_CR33","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1001\/archneur.1984.04050140035014","volume":"41","author":"RR Skoglund","year":"1984","unstructured":"Skoglund RR (1984) Ataxia-telangiectasia. Arch Neurol 41(2):137\u2013137","journal-title":"Arch Neurol"},{"issue":"1","key":"9078_CR34","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1207\/S15326942DN1701_04","volume":"17","author":"SH Mostofsky","year":"2000","unstructured":"Mostofsky SH, Kunze JC, Cutting LE, Lederman HM, Denckla MB (2000) Judgment of duration in individuals with ataxia-telangiectasia. Dev Neuropsychol 17(1):63\u201374","journal-title":"Dev Neuropsychol"},{"key":"9078_CR35","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s10048-014-0415-z","volume":"15","author":"EC Gilmore","year":"2014","unstructured":"Gilmore EC (2014) DNA repair abnormalities leading to ataxia: shared neurological phenotypes and risk factors. Neurogenetics 15:217\u2013228","journal-title":"Neurogenetics"},{"issue":"7","key":"9078_CR36","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1111\/dmcn.13052","volume":"58","author":"TJ Jackson","year":"2016","unstructured":"Jackson TJ, Chow G, Suri M, Byrd P, Taylor MR, Whitehouse WP (2016) Longitudinal analysis of the neurological features of ataxia-telangiectasia. Dev Med Child Neurol 58(7):690\u2013697","journal-title":"Dev Med Child Neurol"},{"key":"9078_CR37","first-page":"233","volume":"19","author":"H Vinters","year":"1985","unstructured":"Vinters H, Gatti R, Rakic P (1985) Sequence of cellular events in cerebellar ontogeny relevant to expression of neuronal abnormalities in ataxia-telangiectasia. Kroc Found Ser 19:233\u2013255","journal-title":"Kroc Found Ser"},{"issue":"2","key":"9078_CR38","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1002\/mds.29645","volume":"39","author":"R Presterud","year":"2024","unstructured":"Presterud R, Deng WH, Wennerstr\u00f6m AB, Burgers T, Gajera B, Mattsson K, Solberg A, Fang EF, Nieminen AI, Stray-Pedersen A (2024) Long-term nicotinamide riboside use improves coordination and eye movements in ataxia telangiectasia. Mov Disord 39(2):360\u2013369","journal-title":"Mov Disord"},{"issue":"11","key":"9078_CR39","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1136\/jmg-2022-109127","volume":"60","author":"A Mohajeri","year":"2023","unstructured":"Mohajeri A, Vaseghi-Shanjani M, Rosenfeld JA, Yang GX, Lu H, Sharma M, Lin S, Salman A, Waqas M, Azamian MS (2023) Dominant negative variants in IKZF2 cause ICHAD syndrome, a new disorder characterised by immunodysregulation, craniofacial anomalies, hearing impairment, athelia and developmental delay. J Med Genet 60(11):1092\u20131104","journal-title":"J Med Genet"},{"issue":"3","key":"9078_CR40","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1002\/ajmg.1320570321","volume":"57","author":"K Chrzanowska","year":"1995","unstructured":"Chrzanowska K, Kleijer W, Krajewska-Walasek M, Bia\u0142ecka M, Gutkowska A, Goryluk-Kozakiewicz B, Micha\u0142kiewicz J, Stachowski J, Gregorek H, \u0141ys\u00f3n-Wojciechowska G (1995) Eleven Polish patients with microcephaly, immunodeficiency, and chromosomal instability: the Nijmegen breakage syndrome. Am J Med Genet 57(3):462\u2013471","journal-title":"Am J Med Genet"},{"issue":"3","key":"9078_CR41","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.pediatrneurol.2003.07.003","volume":"30","author":"P Seeman","year":"2004","unstructured":"Seeman P, Gebertov\u00e1 K, Pad\u011brov\u00e1 K, Sperling K, Seemanov\u00e1 E (2004) Nijmegen breakage syndrome in 13% of age-matched Czech children with primary microcephaly. Pediatr Neurol 30(3):195\u2013200","journal-title":"Pediatr Neurol"},{"issue":"4","key":"9078_CR42","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1111\/j.1651-2227.1981.tb05740.x","volume":"70","author":"C Weemaes","year":"1981","unstructured":"Weemaes C, Hustinx T, Scheres J, Munster Pv, Bakkeren J, Taalman R (1981) A new chromosomal instability disorder: the Nijmegen breakage syndrome. Acta Paediatrica 70(4):557\u2013564","journal-title":"Acta Paediatrica"},{"issue":"3","key":"9078_CR43","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.dnarep.2010.12.002","volume":"10","author":"Y Matsumoto","year":"2011","unstructured":"Matsumoto Y, Miyamoto T, Sakamoto H, Izumi H, Nakazawa Y, Ogi T, Tahara H, Oku S, Hiramoto A, Shiiki T (2011) Two unrelated patients with MRE11A mutations and Nijmegen breakage syndrome-like severe microcephaly. DNA Repair 10(3):314\u2013321","journal-title":"DNA Repair"},{"key":"9078_CR44","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s002340050011","volume":"42","author":"M Bekiesi\u0144ska-Figatowska","year":"2000","unstructured":"Bekiesi\u0144ska-Figatowska M, Chrzanowska K, Sikorska J, Walecki J, Krajewska-Walasek M, J\u00f3\u017awiak S, Kleijer W (2000) Cranial MRI in the Nijmegen breakage syndrome. Neuroradiology 42:43\u201347","journal-title":"Neuroradiology"},{"issue":"5","key":"9078_CR45","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1136\/adc.82.5.400","volume":"82","author":"I The","year":"2000","unstructured":"The I (2000) Nijmegen breakage syndrome. Arch Dis Child 82(5):400","journal-title":"Arch Dis Child"},{"issue":"1","key":"9078_CR46","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1002\/(SICI)1096-8628(19970502)70:1<24::AID-AJMG5>3.0.CO;2-R","volume":"70","author":"P P\u00e9rez-Vera","year":"1997","unstructured":"P\u00e9rez-Vera P, Gonz\u00e1lez-del Angel A, Molina B, G\u00f3mez L, Fr\u00edas S, Gatti RA, Carnevale A (1997) Chromosome instability with bleomycin and x-ray hypersensitivity in a boy with Nijmegen breakage syndrome. Am J Med Genet 70(1):24\u201327","journal-title":"Am J Med Genet"},{"issue":"6","key":"9078_CR47","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/j.ijporl.2009.01.003","volume":"73","author":"D Gupta","year":"2009","unstructured":"Gupta D, Nagarkar A (2009) Speech impairment in Nijmegen breakage syndrome: a rare anomaly. Int J Pediatr Otorhinolaryngol 73(6):873\u2013875","journal-title":"Int J Pediatr Otorhinolaryngol"},{"issue":"5","key":"9078_CR48","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1136\/jmg.30.5.429","volume":"30","author":"G Gimelli","year":"1993","unstructured":"Gimelli G, Varone P, Pezzolo A, Lerone M, Pistoia V (1993) ICF syndrome with variable expression in sibs. J Med Genet 30(5):429\u2013432","journal-title":"J Med Genet"},{"issue":"3","key":"9078_CR49","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1002\/ajmg.a.30135","volume":"129","author":"T Kubota","year":"2004","unstructured":"Kubota T, Furuumi H, Kamoda T, Iwasaki N, Tobita N, Fujiwara N, Yi Goto, Matsui A, Sasaki H, Kajii T (2004) ICF syndrome in a girl with DNA hypomethylation but without detectable DNMT3B mutation. Am J Med Genet A 129(3):290\u2013293","journal-title":"Am J Med Genet A"},{"issue":"11","key":"9078_CR50","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1038\/ejhg.2013.40","volume":"21","author":"CM Weemaes","year":"2013","unstructured":"Weemaes CM, Van Tol MJ, Wang J, van Ostaijen-Ten Dam MM, Van Eggermond MC, Thijssen PE, Aytekin C, Brunetti-Pierri N, Van Der Burg M, Graham Davies E (2013) Heterogeneous clinical presentation in ICF syndrome: correlation with underlying gene defects. Eur J Hum Genet 21(11):1219\u20131225","journal-title":"Eur J Hum Genet"},{"issue":"3","key":"9078_CR51","first-page":"410","volume":"23","author":"A Aminorroaya","year":"2023","unstructured":"Aminorroaya A, Rayzan E, Shahkarami S, Seyedpour S, Zoghi S, Aryan Z, Somekh I, Rohlfs M, Klein C, Esmaeilzadeh H (2023) Novel DNMT3B mutation in a patient with immunodeficiency, centromeric instability, and facial anomalies (ICF) syndrome and a bronchopulmonary collateral artery. Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets-Immune, Endocrine & Metabolic Disorders 23(3):410\u2013415","journal-title":"Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets-Immune, Endocrine & Metabolic Disorders"},{"issue":"8","key":"9078_CR52","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1002\/ajmg.a.35486","volume":"158","author":"M Cerbone","year":"2012","unstructured":"Cerbone M, Wang J, Van der Maarel SM, D\u2019Amico A, D\u2019Agostino A, Romano A, Brunetti-Pierri N (2012) Immunodeficiency, centromeric instability, facial anomalies (ICF) syndrome, due to ZBTB24 mutations, presenting with large cerebral cyst. Am J Med Genet A 158(8):2043\u20132046","journal-title":"Am J Med Genet A"},{"issue":"5","key":"9078_CR53","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/s10038-023-01121-9","volume":"68","author":"H Kaneko","year":"2023","unstructured":"Kaneko H, Kawase C, Seki J, Ikawa Y, Yachie A, Funato M (2023) Intellectual disability and abnormal cortical neuron phenotypes in patients with Bloom syndrome. J Hum Genet 68(5):321\u2013327","journal-title":"J Hum Genet"},{"issue":"1","key":"9078_CR54","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3315\/jdcr.2012.1086","volume":"6","author":"A Masmoudi","year":"2012","unstructured":"Masmoudi A, Marrakchi S, Kamoun H, Chaaben H, Salah GB, Salah RB, Fakhfakh F, Zahaf A, Turki H (2012) Clinical and laboratory findings in 8 patients with Bloom\u2019s syndrome. J Dermatol Case Rep 6(1):29","journal-title":"J Dermatol Case Rep"},{"issue":"2","key":"9078_CR55","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1002\/ajmg.1320180205","volume":"18","author":"C Werner-Favre","year":"1984","unstructured":"Werner-Favre C, Wyss M, Cabrol C, F\u00e9lix F, Guenin R, Laufer D, Engel E (1984) Cytogenetic study in a mentally retarded child with Bloom syndrome and acute lymphoblastic leukemia. Am J Med Genet 18(2):215\u2013221","journal-title":"Am J Med Genet"},{"issue":"43","key":"9078_CR56","doi-asserted-by":"publisher","first-page":"16910","DOI":"10.1073\/pnas.0708408104","volume":"104","author":"GS Stewart","year":"2007","unstructured":"Stewart GS, Stankovic T, Byrd PJ, Wechsler T, Miller ES, Huissoon A, Drayson MT, West SC, Elledge SJ, Taylor AMR (2007) RIDDLE immunodeficiency syndrome is linked to defects in 53BP1-mediated DNA damage signaling. Proc Natl Acad Sci 104(43):16910\u201316915","journal-title":"Proc Natl Acad Sci"},{"key":"9078_CR57","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01683","volume":"8","author":"B Pietrucha","year":"2017","unstructured":"Pietrucha B, Heropolita\u0144ska-Pliszka E, Geffers R, En\u00dfen J, Wieland B, Bogdanova NV, D\u00f6rk T (2017) Clinical and biological manifestation of RNF168 deficiency in two polish siblings. Front Immunol 8","journal-title":"Front Immunol"},{"key":"9078_CR58","doi-asserted-by":"crossref","unstructured":"Vorstman JA, Morcus ME, Duijff SN, Klaassen PW, Beemer FA, Swaab H, Kahn RS, van Engeland H (2006) The 22q11. 2 deletion in children: high rate of autistic disorders and early onset of psychotic symptoms. J Am Acad Child Adolesc Psychiatry 45(9):1104\u20131113","DOI":"10.1097\/01.chi.0000228131.56956.c1"},{"issue":"12","key":"9078_CR59","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1002\/aur.3049","volume":"16","author":"KP O'Hora","year":"2023","unstructured":"O\u2019Hora KP, Kushan-Wells L, Schleifer CH, Cruz S, Hoftman GD, Jalbrzikowski M, Gur RE, Gur RC, Bearden CE (2023) Distinct neurocognitive profiles and clinical phenotypes associated with copy number variation at the 22q11. 2 locus. Autism Research 16(12):2247\u20132262","journal-title":"Autism Research"},{"issue":"1","key":"9078_CR60","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1097\/00125817-200101000-00011","volume":"3","author":"S Eliez","year":"2001","unstructured":"Eliez S, Blasey CM, Menon V, White CD, Schmitt JE, Reiss AL (2001) Functional brain imaging study of mathematical reasoning abilities in velocardiofacial syndrome (del22q11. 2). Genet Med 3(1):49\u201355","journal-title":"Genet Med"},{"issue":"2","key":"9078_CR61","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1002\/(SICI)1096-8628(19990716)85:2<127::AID-AJMG6>3.0.CO;2-F","volume":"85","author":"M Gerdes","year":"1999","unstructured":"Gerdes M, Solot C, Wang PP, Moss E, LaRossa D, Randall P, Goldmuntz E, Clark BJ III, Driscoll DA, Jawad A (1999) Cognitive and behavior profile of preschool children with chromosome 22q11. 2 deletion. Am J Med Genet 85(2):127\u2013133","journal-title":"Am J Med Genet"},{"issue":"2","key":"9078_CR62","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/S0022-3476(99)70415-4","volume":"134","author":"EM Moss","year":"1999","unstructured":"Moss EM, Batshaw ML, Solot CB, Gerdes M, McDonald-McGinn DM, Driscoll DA, Emanuel BS, Zackai EH, Wang PP (1999) Psychoeducational profile of the 22q11. 2 microdeletion: a complex pattern. J Pediatr 134(2):193\u2013198","journal-title":"J Pediatr"},{"issue":"2","key":"9078_CR63","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1089\/gte.1997.1.99","volume":"1","author":"DM McDONALD-McGINN","year":"1997","unstructured":"McDONALD-McGINN DM, LaRossa D, GOLDMUNTZ E, SULLIVAN K, EICHER P, GERDES M, MOSS E, WANG P, SOLOT C, SCHULTZ P (1997) The 22q11. 2 deletion: screening, diagnostic workup, and outcome of results; report on 181 patients. Genetic testing 1(2):99\u2013108","journal-title":"Genetic testing"},{"issue":"3","key":"9078_CR64","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/S0022-3476(05)81740-8","volume":"123","author":"B Motzkin","year":"1993","unstructured":"Motzkin B, Marion R, Goldberg R, Shprintzen R, Saenger P (1993) Variable phenotypes in velocardiofacial syndrome with chromosomal deletion. J Pediatr 123(3):406\u2013410","journal-title":"J Pediatr"},{"issue":"6","key":"9078_CR65","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1136\/jmg.34.6.453","volume":"34","author":"A Swillen","year":"1997","unstructured":"Swillen A, Devriendt K, Legius E, Eyskens B, Dumoulin M, Gewillig M, Fryns J (1997) Intelligence and psychosocial adjustment in velocardiofacial syndrome: a study of 37 children and adolescents with VCFS. J Med Genet 34(6):453\u2013458","journal-title":"J Med Genet"},{"issue":"4","key":"9078_CR66","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1076\/0929-7049(199912)05:04;1-R;FT230","volume":"5","author":"A Swillen","year":"1999","unstructured":"Swillen A, Vandeputte L, Cracco J, Maes B, Ghesqui\u00e8re P, Devriendt K, Fryns J-P (1999) Neuropsychological, learning and psychosocial profile of primary school aged children with the velo-cardio-facial syndrome (22q11 deletion): evidence for a nonverbal learning disability? Child Neuropsychol 5(4):230\u2013241","journal-title":"Child Neuropsychol"},{"issue":"4","key":"9078_CR67","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1002\/ajmg.a.30984","volume":"138","author":"AS Bassett","year":"2005","unstructured":"Bassett AS, Chow EW, Husted J, Weksberg R, Caluseriu O, Webb GD, Gatzoulis MA (2005) Clinical features of 78 adults with 22q11 deletion syndrome. Am J Med Genet A 138(4):307\u2013313","journal-title":"Am J Med Genet A"},{"issue":"4","key":"9078_CR68","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1076\/jcen.23.4.447.1228","volume":"23","author":"CE Bearden","year":"2001","unstructured":"Bearden CE, Woodin MF, Wang PP, Moss E, McDonald-McGinn D, Zackai E, Emannuel B, Cannon TD (2001) The neurocognitive phenotype of the 22q11. 2 deletion syndrome: selective deficit in visual-spatial memory. J Clin Exp Neuropsychol 23(4):447\u2013464","journal-title":"J Clin Exp Neuropsychol"},{"issue":"1","key":"9078_CR69","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1111\/j.1469-8749.2002.tb00258.x","volume":"44","author":"L Niklasson","year":"2002","unstructured":"Niklasson L, Rasmussen P, \u00d3skarsd\u00f3ttir S, Gillberg C (2002) Chromosome 22q11 deletion syndrome (CATCH 22): neuropsychiatric and neuropsychological aspects. Dev Med Child Neurol 44(1):44\u201350","journal-title":"Dev Med Child Neurol"},{"issue":"1","key":"9078_CR70","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.biopsych.2007.02.022","volume":"63","author":"F Andersson","year":"2008","unstructured":"Andersson F, Glaser B, Spiridon M, Debban\u00e9 M, Vuilleumier P, Eliez S (2008) Impaired activation of face processing networks revealed by functional magnetic resonance imaging in 22q11. 2 deletion syndrome. Biological psychiatry 63(1):49\u201357","journal-title":"Biological psychiatry"},{"issue":"2","key":"9078_CR71","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1352\/0895-8017(2007)112[79:VSMIIW]2.0.CO;2","volume":"112","author":"S Majerus","year":"2007","unstructured":"Majerus S, Van der Linden M, Braissand V, Eliez S (2007) Verbal short-term memory in individuals with chromosome 22q11. 2 deletion: specific deficit in serial order retention capacities? Am J Mental Retardatio 112(2):79\u201393","journal-title":"Am J Mental Retardatio"},{"issue":"4","key":"9078_CR72","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1002\/ajmg.a.38199","volume":"173","author":"P Kruszka","year":"2017","unstructured":"Kruszka P, Addissie YA, McGinn DE, Porras AR, Biggs E, Share M, Crowley TB, Chung BH, Mok GT, Mak CC (2017) 22q11. 2 deletion syndrome in diverse populations. Am J Med Genet A 173(4):879\u2013888","journal-title":"Am J Med Genet A"},{"issue":"5","key":"9078_CR73","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1111\/j.1399-0004.2009.01234.x","volume":"76","author":"G Repetto","year":"2009","unstructured":"Repetto G, Guzm\u00e1n M, Puga A, Calder\u00f3n J, Astete C, Aracena M, Arriaza M, Aravena T, Sanz P (2009) Clinical features of chromosome 22q11. 2 microdeletion syndrome in 208 Chilean patients. Clinical genetics 76(5):465\u2013470","journal-title":"Clinical genetics"},{"key":"9078_CR74","first-page":"382","volume":"103","author":"MS Grassi","year":"2014","unstructured":"Grassi MS, Jacob C, Kulikowski LD, Pastorino AC, Dutra RL, Miura N, Jatene MB, Pegler SP, Kim CA, Carneiro-Sampaio M (2014) Congenital heart disease as a warning sign for the diagnosis of the 22q11. 2 deletion. Arquivos brasileiros de cardiologia 103:382\u2013390","journal-title":"Arquivos brasileiros de cardiologia"},{"issue":"1","key":"9078_CR75","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0054404","volume":"8","author":"D Wu","year":"2013","unstructured":"Wu D, Chen Y, Xu C, Wang K, Wang H, Zheng F, Ma D, Wang G (2013) Characteristic face: a key indicator for direct diagnosis of 22q11. 2 deletions in Chinese velocardiofacial syndrome patients. PLoS One 8(1)","journal-title":"PLoS One"},{"issue":"9","key":"9078_CR76","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1002\/ajmg.a.34226","volume":"155","author":"A Veerapandiyan","year":"2011","unstructured":"Veerapandiyan A, Abdul-Rahman OA, Adam MP, Lyons MJ, Manning M, Coleman K, Kobrynski L, Taneja D, Schoch K, Zimmerman HH (2011) Chromosome 22q11. 2 deletion syndrome in African-American patients: a diagnostic challenge. American Journal of Medical Genetics Part A 155(9):2186\u20132195","journal-title":"American Journal of Medical Genetics Part A"},{"issue":"3","key":"9078_CR77","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1002\/ajmg.a.30069","volume":"134","author":"DM McDonald-McGinn","year":"2005","unstructured":"McDonald-McGinn DM, Minugh-Purvis N, Kirschner RE, Jawad A, Tonnesen MK, Catanzaro JR, Goldmuntz E, Driscoll D, LaRossa D, Emanuel BS (2005) The 22q11. 2 deletion in African-American patients: an underdiagnosed population? American Journal of Medical Genetics Part A 134(3):242\u2013246","journal-title":"American Journal of Medical Genetics Part A"},{"issue":"8","key":"9078_CR78","doi-asserted-by":"publisher","first-page":"2158","DOI":"10.1002\/ajmg.a.38304","volume":"173","author":"LA Bohm","year":"2017","unstructured":"Bohm LA, Zhou TC, Mingo TJ, Dugan SL, Patterson RJ, Sidman JD, Roby BB (2017) Neuroradiographic findings in 22q11. 2 deletion syndrome. American Journal of Medical Genetics Part A 173(8):2158\u20132165","journal-title":"American Journal of Medical Genetics Part A"},{"key":"9078_CR79","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s11689-021-09363-4","volume":"13","author":"R Jalal","year":"2021","unstructured":"Jalal R, Nair A, Lin A, Eckfeld A, Kushan L, Zinberg J, Karlsgodt KH, Cannon TD, Bearden CE (2021) Social cognition in 22q11. 2 deletion syndrome and idiopathic developmental neuropsychiatric disorders. Journal of neurodevelopmental disorders 13:1\u201315","journal-title":"Journal of neurodevelopmental disorders"},{"issue":"7","key":"9078_CR80","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.3390\/genes14071347","volume":"14","author":"J-E Lorena","year":"2023","unstructured":"Lorena J-E, Sandra P-R (2023) Description of neuropsychological profile in patients with 22q11 syndrome. Genes 14(7):1347","journal-title":"Genes"},{"key":"9078_CR81","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12920-020-00849-z","volume":"14","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Liu X, Gao H, He R, Zhao Y (2021) Identifying of 22q11. 2 variations in Chinese patients with development delay. BMC Medical Genomics 14:1\u20139","journal-title":"BMC Medical Genomics"},{"issue":"11","key":"9078_CR82","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.3390\/genes13112038","volume":"13","author":"T Heung","year":"2022","unstructured":"Heung T, Conroy B, Malecki S, Ha J, Boot E, Corral M, Bassett AS (2022) Adult height, 22q11. 2 deletion extent, and short stature in 22q11. 2 deletion syndrome. Genes 13(11):2038","journal-title":"Genes"},{"issue":"4","key":"9078_CR83","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1093\/schbul\/sbx113","volume":"44","author":"M Niarchou","year":"2018","unstructured":"Niarchou M, Calkins ME, Moore TM, Tang SX, McDonald-McGinn DM, Zackai EH, Emanuel BS, Gur RC, Gur RE (2018) Attention deficit hyperactivity disorder symptoms and psychosis in 22q11. 2 deletion syndrome. Schizophrenia Bulletin 44(4):824\u2013833","journal-title":"Schizophrenia Bulletin"},{"issue":"1","key":"9078_CR84","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1044\/2022_AJSLP-21-00328","volume":"32","author":"E Everaert","year":"2023","unstructured":"Everaert E, Selten I, Boerma T, Houben M, Vorstman J, de Wilde H, Derksen D, Haverkamp S, Wijnen F, Gerrits E (2023) The language profile of preschool children with 22q11. 2 deletion syndrome and the relationship with speech intelligibility. American journal of speech-language pathology 32(1):128\u2013144","journal-title":"American journal of speech-language pathology"},{"issue":"8","key":"9078_CR85","doi-asserted-by":"publisher","first-page":"3655","DOI":"10.1093\/cercor\/bhy239","volume":"29","author":"M Gudbrandsen","year":"2019","unstructured":"Gudbrandsen M, Daly E, Murphy C, Wichers R, Stoencheva V, Perry E, Andrews D, Blackmore C, Rogdaki M, Kushan L (2019) The neuroanatomy of autism spectrum disorder symptomatology in 22q11. 2 deletion syndrome. Cerebral Cortex 29(8):3655\u20133665","journal-title":"Cerebral Cortex"},{"issue":"1","key":"9078_CR86","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1192\/bjp.2017.6","volume":"212","author":"AC Cunningham","year":"2018","unstructured":"Cunningham AC, Delport S, Cumines W, Busse M, Linden DE, Hall J, Owen MJ, van den Bree MB (2018) Developmental coordination disorder, psychopathology and IQ in 22q11. 2 deletion syndrome. The British Journal of Psychiatry 212(1):27\u201333","journal-title":"The British Journal of Psychiatry"},{"key":"9078_CR87","doi-asserted-by":"publisher","first-page":"3076","DOI":"10.1007\/s10803-021-05172-9","volume":"52","author":"LE Campbell","year":"2022","unstructured":"Campbell LE, Swaab L, Freeman EE et al (2022) The importance of understanding individual differences of emotion regulation abilities in 22q11.2 deletion syndrome. J Autism Dev Disord 52:3076\u20133087. https:\/\/doi.org\/10.1007\/s10803-021-05172-9","journal-title":"J Autism Dev Disord"},{"issue":"6","key":"9078_CR88","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1093\/jpepsy\/jsy002","volume":"43","author":"LE Taylor","year":"2018","unstructured":"Taylor LE, Kates WR, Fremont W, Antshel KM (2018) Young adult outcomes for children with 22q11 deletion syndrome and comorbid ADHD. J Pediatr Psychol 43(6):636\u2013644","journal-title":"J Pediatr Psychol"},{"key":"9078_CR89","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.jcomdis.2018.06.001","volume":"75","author":"E Van Den Heuvel","year":"2018","unstructured":"Van Den Heuvel E, Manders E, Swillen A, Zink I (2018) Atypical language characteristics and trajectories in children with 22q11. 2 deletion syndrome. Journal of communication disorders 75:37\u201356","journal-title":"Journal of communication disorders"},{"issue":"5","key":"9078_CR90","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.3390\/ijms18051071","volume":"18","author":"O Ousley","year":"2017","unstructured":"Ousley O, Evans AN, Fernandez-Carriba S, Smearman EL, Rockers K, Morrier MJ, Evans DW, Coleman K, Cubells J (2017) Examining the overlap between autism spectrum disorder and 22q11. 2 deletion syndrome. International journal of molecular sciences 18(5):1071","journal-title":"International journal of molecular sciences"},{"issue":"4","key":"9078_CR91","first-page":"287","volume":"25","author":"HY AlKalaf","year":"2020","unstructured":"AlKalaf HY, AlHashem AM, AlSaleh NS, AlJohar NM, Thneen AMA, ElGhezal HM, Bouhjar IB, Tlili-Graiess K, Sahari AH (2020) Tabarki BM: Epilepsy, neuropsychiatric phenotypes, neuroimaging findings, and genotype-neurophenotype correlation in 22q11. 2 deletion syndrome. Neurosci J 25(4):287\u2013291","journal-title":"Neurosci J"},{"issue":"1","key":"9078_CR92","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1002\/ajmg.b.32005","volume":"159","author":"PC Goldenberg","year":"2012","unstructured":"Goldenberg PC, Calkins ME, Richard J, McDonald-McGinn D, Zackai E, Mitra N, Emanuel B, Devoto M, Borgmann-Winter K, Kohler C (2012) Computerized neurocognitive profile in young people with 22q11. 2 deletion syndrome compared to youths with schizophrenia and at-risk for psychosis. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 159(1):87\u201393","journal-title":"American Journal of Medical Genetics Part B: Neuropsychiatric Genetics"},{"issue":"3","key":"9078_CR93","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1002\/ajmg.a.32650","volume":"149","author":"C Zaleski","year":"2009","unstructured":"Zaleski C, Bassett AS, Tam K, Shugar AL, Chow EW, McPherson E (2009) The co-occurrence of early onset Parkinson disease and 22q11. 2 deletion syndrome. American journal of medical genetics Part A 149(3):525","journal-title":"American journal of medical genetics Part A"},{"issue":"6","key":"9078_CR94","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.neurol.2017.03.021","volume":"173","author":"B Dufournet","year":"2017","unstructured":"Dufournet B, Nguyen K, Charles P, Grabli D, Jacquette A, Borg M, Danaila T, Mutez E, Drapier S, Colin O (2017) Parkinson\u2019s disease associated with 22q11. 2 deletion: clinical characteristics and response to treatment. Revue Neurologique 173(6):406\u2013410","journal-title":"Revue Neurologique"},{"issue":"23","key":"9078_CR95","doi-asserted-by":"publisher","first-page":"e2059","DOI":"10.1212\/WNL.0000000000005660","volume":"90","author":"E Boot","year":"2018","unstructured":"Boot E, Butcher NJ, Udow S, Marras C, Mok KY, Kaneko S, Barrett MJ, Prontera P, Berman BD, Masellis M (2018) Typical features of Parkinson disease and diagnostic challenges with microdeletion 22q11. 2. Neurology 90(23):e2059\u2013e2067","journal-title":"Neurology"},{"issue":"7","key":"9078_CR96","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1002\/mds.28080","volume":"35","author":"E Boot","year":"2020","unstructured":"Boot E, Mentzel TQ, Palmer LD, Van Harten PN, Marras C, Lang AE, Bassett AS (2020) Age\u2010related parkinsonian signs in microdeletion 22q11. 2. Move Disord 35(7):1239\u20131245","journal-title":"Move Disord"},{"issue":"10","key":"9078_CR97","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1001\/archpsyc.56.10.940","volume":"56","author":"KC Murphy","year":"1999","unstructured":"Murphy KC, Jones LA, Owen MJ (1999) High rates of schizophrenia in adults with velo-cardio-facial syndrome. Arch Gen Psychiatry 56(10):940\u2013945","journal-title":"Arch Gen Psychiatry"},{"issue":"1","key":"9078_CR98","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.biopsych.2016.08.034","volume":"82","author":"SX Tang","year":"2017","unstructured":"Tang SX, Moore TM, Calkins ME, Yi JJ, Savitt A, Kohler CG, Souders MC, Zackai EH, McDonald-McGinn DM, Emanuel BS (2017) The psychosis spectrum in 22q11. 2 deletion syndrome is comparable to that of nondeleted youths. Biological Psychiatry 82(1):17\u201325","journal-title":"Biological Psychiatry"},{"issue":"6","key":"9078_CR99","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1017\/S0033291713001669","volume":"44","author":"S Tang","year":"2014","unstructured":"Tang S, Yi J, Calkins M, Whinna D, Kohler C, Souders M, McDonald-McGinn D, Zackai E, Emanuel B, Gur R (2014) Psychiatric disorders in 22q11. 2 deletion syndrome are prevalent but undertreated. Psychol Med 44(6):1267\u20131277","journal-title":"Psychological medicine"},{"issue":"12","key":"9078_CR100","doi-asserted-by":"publisher","first-page":"3071","DOI":"10.1002\/ajmg.a.35589","volume":"158","author":"C Persson","year":"2012","unstructured":"Persson C, Friman V, \u00d3skarsd\u00f3ttir S, J\u00f6nsson R (2012) Speech and hearing in adults with 22q11. 2 deletion syndrome. American journal of medical genetics Part A 158(12):3071\u20133079","journal-title":"American journal of medical genetics Part A"},{"issue":"10","key":"9078_CR101","doi-asserted-by":"publisher","first-page":"4021","DOI":"10.1007\/s10803-022-05675-z","volume":"53","author":"AF Sanders","year":"2023","unstructured":"Sanders AF, Hobbs DA, Knaus TA, Beaton EA (2023) Structural connectivity and emotion recognition impairment in children and adolescents with chromosome 22q11. 2 deletion syndrome. Journal of autism and developmental disorders 53(10):4021\u20134034","journal-title":"Journal of autism and developmental disorders"},{"issue":"1","key":"9078_CR102","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1097\/MCD.0000000000000014","volume":"23","author":"S Pisano","year":"2014","unstructured":"Pisano S, Milone A, Gemo I, Masi G (2014) High-functioning autism spectrum disorder associated with CHARGE syndrome: a case report. Clin Dysmorphol 23(1):35\u201337","journal-title":"Clin Dysmorphol"},{"issue":"12","key":"9078_CR103","doi-asserted-by":"publisher","first-page":"3042","DOI":"10.1002\/ajmg.a.36758","volume":"164","author":"L Santoro","year":"2014","unstructured":"Santoro L, Ficcadenti A, Zallocco F, Baldo GD, Piraccini F, Gesuita R, Ceccarani P, Gabrielli O (2014) Cognitive-motor profile, clinical characteristics and diagnosis of CHARGE syndrome: an Italian experience. Am J Med Genet A 164(12):3042\u20133051","journal-title":"Am J Med Genet A"},{"key":"9078_CR104","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13023-020-01421-9","volume":"15","author":"V Abadie","year":"2020","unstructured":"Abadie V, Hamiaux P, Ragot S, Legendre M, Malecot G, Burtin A, Attie-Bitach T, Lyonnet S, Bilan F, Gilbert-Dussardier B (2020) Should autism spectrum disorder be considered part of CHARGE syndrome? A cross-sectional study of 46 patients. Orphanet J Rare Dis 15:1\u201314","journal-title":"Orphanet J Rare Dis"},{"issue":"9","key":"9078_CR105","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1016\/j.ijporl.2012.05.021","volume":"76","author":"J Dammeyer","year":"2012","unstructured":"Dammeyer J (2012) Development and characteristics of children with Usher syndrome and CHARGE syndrome. Int J Pediatr Otorhinolaryngol 76(9):1292\u20131296","journal-title":"Int J Pediatr Otorhinolaryngol"},{"issue":"8","key":"9078_CR106","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1002\/ajmg.a.37692","volume":"170","author":"A Vesseur","year":"2016","unstructured":"Vesseur A, Langereis M, Free R, Snik A, van Ravenswaaij-Arts C, Mylanus E (2016) Influence of hearing loss and cognitive abilities on language development in CHARGE syndrome. Am J Med Genet A 170(8):2022\u20132030","journal-title":"Am J Med Genet A"},{"issue":"2","key":"9078_CR107","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/j.1399-0004.2012.01884.x","volume":"83","author":"E Husu","year":"2013","unstructured":"Husu E, Hove H, Farholt S, Bille M, Tranebj\u00e6rg L, Vogel I, Kreiborg S (2013) Phenotype in 18 Danish subjects with genetically verified CHARGE syndrome. Clin Genet 83(2):125\u2013134","journal-title":"Clin Genet"},{"issue":"10","key":"9078_CR108","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1080\/00207454.2023.2240485","volume":"134","author":"L Skei","year":"2024","unstructured":"Skei L, Skei S, von Tetzchner S, Hartshorne T, Landr\u00f8 NI (2024) The assessment and diagnosis of intellectual disability when development is atypical. A Norwegian population study of individuals with CHARGE syndrome. International Journal of Neuroscience 134(10):1120\u20131133","journal-title":"International Journal of Neuroscience"},{"issue":"3","key":"9078_CR109","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1002\/ajmg.a.30544","volume":"133","author":"IM Smith","year":"2005","unstructured":"Smith IM, Nichols SL, Issekutz K, Blake K (2005) Behavioral profiles and symptoms of autism in CHARGE syndrome: preliminary Canadian epidemiological data. Am J Med Genet A 133(3):248\u2013256","journal-title":"Am J Med Genet A"},{"issue":"7","key":"9078_CR110","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1111\/j.1469-8749.2003.tb00944.x","volume":"45","author":"F Raqbi","year":"2003","unstructured":"Raqbi F, Le Bihan C, Morisseau-Durand M, Dureau P, Lyonnet S, Abadie V (2003) Early prognostic factors for intellectual outcome in CHARGE syndrome. Dev Med Child Neurol 45(7):483\u2013488","journal-title":"Dev Med Child Neurol"},{"key":"9078_CR111","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s10792-012-9653-y","volume":"33","author":"N Pushker","year":"2013","unstructured":"Pushker N, Tinwala S, Khurana S, Sen S (2013) Bilateral microphthalmos with unilateral superior cyst in a child with autism and CHARGE syndrome. Int Ophthalmol 33:195\u2013198","journal-title":"Int Ophthalmol"},{"issue":"1","key":"9078_CR112","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1542\/peds.110.1.119","volume":"110","author":"BM Edwards","year":"2002","unstructured":"Edwards BM, Kileny PR, Van Riper LA (2002) CHARGE syndrome: a window of opportunity for audiologic intervention. Pediatrics 110(1):119\u2013126","journal-title":"Pediatrics"},{"issue":"10","key":"9078_CR113","doi-asserted-by":"publisher","first-page":"5632","DOI":"10.3390\/ijms23105632","volume":"23","author":"AJ Paganoni","year":"2022","unstructured":"Paganoni AJ, Amoruso F, Porta Pelayo J, Calleja-P\u00e9rez B, Vezzoli V, Duminuco P, Caramello A, Oleari R, Fern\u00e1ndez-Ja\u00e9n A, Cariboni A (2022) A novel loss-of-function SEMA3E mutation in a patient with severe intellectual disability and cognitive regression. Int J Mol Sci 23(10):5632","journal-title":"Int J Mol Sci"},{"key":"9078_CR114","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.pediatrneurol.2018.10.022","volume":"92","author":"DN Haffner","year":"2019","unstructured":"Haffner DN, Rollins NK, Dowling MM (2019) Reversible cerebral vasoconstriction syndrome: a novel mechanism for neurological complications in Schimke immuno-osseous dysplasia. Pediatr Neurol 92:67\u201370","journal-title":"Pediatr Neurol"},{"key":"9078_CR115","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1007\/s004310050714","volume":"156","author":"B Schmidt","year":"1997","unstructured":"Schmidt B, Christen H, Herkenrath P, Benz-Bohm G, M\u00fcller-Berghaus J, Querfeld U (1997) Cerebral complications in Schimke immuno-osseous dysplasia. Eur J Pediatr 156:789\u2013791","journal-title":"Eur J Pediatr"},{"issue":"2","key":"9078_CR116","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1002\/ajmg.a.30692","volume":"135","author":"SS Kilic","year":"2005","unstructured":"Kilic SS, Donmez O, Sloan EA, Elizondo LI, Huang C, Andr\u00e9 JL, Bogdanovic R, Cockfield S, Cordeiro I, Deschenes G (2005) Association of migraine-like headaches with Schimke immuno-osseous dysplasia. Am J Med Genet A 135(2):206\u2013210","journal-title":"Am J Med Genet A"},{"key":"9078_CR117","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1007\/s10875-013-9957-3","volume":"34","author":"AJ Simon","year":"2014","unstructured":"Simon AJ, Lev A, Jeison M, Borochowitz ZU, Korn D, Lerenthal Y, Somech R (2014) Novel SMARCAL1 bi-allelic mutations associated with a chromosomal breakage phenotype in a severe SIOD patient. J Clin Immunol 34:76\u201383","journal-title":"J Clin Immunol"},{"issue":"6","key":"9078_CR118","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1034\/j.1399-0004.2000.570606.x","volume":"57","author":"SP Robertson","year":"2000","unstructured":"Robertson SP, Rodda C, Bankier A (2000) Hypogonadotrophic hypogonadism in Roifman syndrome. Clin Genet 57(6):435\u2013438","journal-title":"Clin Genet"},{"issue":"2","key":"9078_CR119","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1017\/S1047951101000208","volume":"11","author":"K Mandel","year":"2001","unstructured":"Mandel K, Grunebaum E, Benson L (2001) Noncompaction of the myocardium associated with Roifman syndrome. Cardiol Young 11(2):240\u2013243","journal-title":"Cardiol Young"},{"issue":"9","key":"9078_CR120","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1111\/j.1365-2788.2006.00817.x","volume":"50","author":"P De Vries","year":"2006","unstructured":"De Vries P, McCartney D, McCartney E, Woolf D, Wozencroft D (2006) The cognitive and behavioural phenotype of Roifman syndrome. J Intellect Disabil Res 50(9):690\u2013696","journal-title":"J Intellect Disabil Res"},{"issue":"2","key":"9078_CR121","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1034\/j.1399-0004.1999.550206.x","volume":"55","author":"CM Roifman","year":"1999","unstructured":"Roifman CM (1999) Antibody deficiency, growth retardation, spondyloepiphyseal dysplasia and retinal dystrophy: a novel syndrome. Clin Genet 55(2):103\u2013109","journal-title":"Clin Genet"},{"issue":"4","key":"9078_CR122","doi-asserted-by":"publisher","first-page":"e249109","DOI":"10.1136\/bcr-2022-249109","volume":"15","author":"D Clifford","year":"2022","unstructured":"Clifford D, Moloney F, Leahy TR, Murray DM (2022) Roifman syndrome: a description of further immunological and radiological features. BMJ Case Reports CP 15(4):e249109","journal-title":"BMJ Case Reports CP"},{"issue":"2","key":"9078_CR123","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.ajhg.2017.01.013","volume":"100","author":"MM Oud","year":"2017","unstructured":"Oud MM, Tuijnenburg P, Hempel M, van Vlies N, Ren Z, Ferdinandusse S, Jansen MH, Santer R, Johannsen J, Bacchelli C (2017) Mutations in EXTL3 cause neuro-immuno-skeletal dysplasia syndrome. The American Journal of Human Genetics 100(2):281\u2013296","journal-title":"The American Journal of Human Genetics"},{"issue":"10","key":"9078_CR124","doi-asserted-by":"publisher","first-page":"3104","DOI":"10.1002\/ajmg.a.62378","volume":"185","author":"A Akal\u0131n","year":"2021","unstructured":"Akal\u0131n A, Taskiran EZ, \u015eim\u015fek-Kiper P\u00d6, Utine E, Alanay Y, \u00d6z\u00e7elik U, Boduro\u011flu K (2021) Spondyloepimetaphyseal dysplasia EXTL3-deficient type: long-term follow-up and review of the literature. Am J Med Genet A 185(10):3104\u20133110","journal-title":"Am J Med Genet A"},{"issue":"5","key":"9078_CR125","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1016\/j.jaci.2014.02.013","volume":"133","author":"Y Zhang","year":"2014","unstructured":"Zhang Y, Yu X, Ichikawa M, Lyons JJ, Datta S, Lamborn IT, Jing H, Kim ES, Biancalana M, Wolfe LA (2014) Autosomal recessive PGM3 mutations link glycosylation defects to atopy, immune deficiency, autoimmunity, and neurocognitive impairment. J Allergy Clin Immunol 133(5):1400","journal-title":"J Allergy Clin Immunol"},{"key":"9078_CR126","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1007\/s10875-021-00985-w","volume":"41","author":"M Fusaro","year":"2021","unstructured":"Fusaro M, Vincent A, Castelle M, Rosain J, Fournier B, Veiga-da-Cunha M, Kentache T, Serre J, Fallet-Bianco C, Delezoide A-L (2021) Two novel homozygous mutations in phosphoglucomutase 3 leading to severe combined immunodeficiency, skeletal dysplasia, and malformations. J Clin Immunol 41:958\u2013966","journal-title":"J Clin Immunol"},{"issue":"6","key":"9078_CR127","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1002\/ajmg.a.62124","volume":"185","author":"SE Sheppard","year":"2021","unstructured":"Sheppard SE, Campbell IM, Harr MH, Gold N, Li D, Bjornsson HT, Cohen JS, Fahrner JA, Fatemi A, Harris JR (2021) Expanding the genotypic and phenotypic spectrum in a diverse cohort of 104 individuals with Wiedemann-Steiner syndrome. Am J Med Genet A 185(6):1649\u20131665","journal-title":"Am J Med Genet A"},{"issue":"2","key":"9078_CR128","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1002\/ajmg.a.60698","volume":"179","author":"HR Feldman","year":"2019","unstructured":"Feldman HR, Dlouhy SR, Lah MD, Payne KK, Weaver DD (2019) The progression of Wiedemann-Steiner syndrome in adulthood and two novel variants in the KMT2A gene. Am J Med Genet A 179(2):300\u2013305","journal-title":"Am J Med Genet A"},{"issue":"2","key":"9078_CR129","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.ajhg.2012.06.008","volume":"91","author":"WD Jones","year":"2012","unstructured":"Jones WD, Dafou D, McEntagart M, Woollard WJ, Elmslie FV, Holder-Espinasse M, Irving M, Saggar AK, Smithson S, Trembath RC (2012) De novo mutations in MLL cause Wiedemann-Steiner syndrome. The American Journal of Human Genetics 91(2):358\u2013364","journal-title":"The American Journal of Human Genetics"},{"issue":"1","key":"9078_CR130","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1111\/cge.13254","volume":"94","author":"S Baer","year":"2018","unstructured":"Baer S, Afenjar A, Smol T, Piton A, Gerard B, Alembik Y, Bienvenu T, Boursier G, Boute O, Colson C (2018) Wiedemann-Steiner syndrome as a major cause of syndromic intellectual disability: a study of 33 French cases. Clin Genet 94(1):141\u2013152","journal-title":"Clin Genet"},{"key":"9078_CR131","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13023-018-0909-0","volume":"13","author":"N Li","year":"2018","unstructured":"Li N, Wang Y, Yang Y, Wang P, Huang H, Xiong S, Sun L, Cheng M, Song C, Cheng X (2018) Description of the molecular and phenotypic spectrum of Wiedemann-Steiner syndrome in Chinese patients. Orphanet J Rare Dis 13:1\u201313","journal-title":"Orphanet J Rare Dis"},{"key":"9078_CR132","doi-asserted-by":"crossref","unstructured":"Byrne S, Jansen L, U-King-Im J-M, Siddiqui A, Lidov HG, Bodi I, Smith L, Mein R, Cullup T, Dionisi-Vici C (2016) EPG5-related Vici syndrome: a paradigm of neurodevelopmental disorders with defective autophagy. Brain 139(3):765-781","DOI":"10.1093\/brain\/awv393"},{"issue":"1","key":"9078_CR133","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1002\/ajmg.10298","volume":"109","author":"T Chiyonobu","year":"2002","unstructured":"Chiyonobu T, Yoshihara T, Fukushima Y, Yamamoto Y, Tsunamoto K, Nishimura Y, Ishida H, Toda T, Kasubuchi Y (2002) Sister and brother with Vici syndrome: agenesis of the corpus callosum, albinism, and recurrent infections. Am J Med Genet 109(1):61\u201366","journal-title":"Am J Med Genet"},{"issue":"2","key":"9078_CR134","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1002\/ajmg.a.31584","volume":"143","author":"R Miyata","year":"2007","unstructured":"Miyata R, Hayashi M, Sato H, Sugawara Y, Yui T, Araki S, Hasegawa T, Doi S, Kohyama J (2007) Sibling cases of Vici syndrome: sleep abnormalities and complications of renal tubular acidosis. American Journal of Medical Genetics Part A 143(2):189\u2013194","journal-title":"American Journal of Medical Genetics Part A"},{"issue":"1","key":"9078_CR135","volume":"2011","author":"RC Rogers","year":"2011","unstructured":"Rogers RC, Aufmuth B, Monesson S (2011) Vici syndrome: a rare autosomal recessive syndrome with brain anomalies, cardiomyopathy, and severe intellectual disability. Case reports in genetics 2011(1)","journal-title":"Case reports in genetics"},{"issue":"2","key":"9078_CR136","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1002\/ajmg.a.34244","volume":"158","author":"A Finocchi","year":"2012","unstructured":"Finocchi A, Angelino G, Cantarutti N, Corbari M, Bevivino E, Cascioli S, Randisi F, Bertini E, Dionisi-Vici C (2012) Immunodeficiency in Vici syndrome: a heterogeneous phenotype. Am J Med Genet A 158(2):434\u2013439","journal-title":"Am J Med Genet A"},{"issue":"5","key":"9078_CR137","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.pediatrneurol.2012.07.007","volume":"47","author":"M \u00d6zkale","year":"2012","unstructured":"\u00d6zkale M, Erol I, G\u00fcm\u00fc\u015f A, \u00d6zkale Y, Alehan F (2012) Vici syndrome associated with sensorineural hearing loss and laryngomalacia. Pediatr Neurol 47(5):375\u2013378","journal-title":"Pediatr Neurol"},{"issue":"12","key":"9078_CR138","doi-asserted-by":"publisher","first-page":"3170","DOI":"10.1002\/ajmg.a.36772","volume":"164","author":"N Ehmke","year":"2014","unstructured":"Ehmke N, Parvaneh N, Krawitz P, Ashrafi MR, Karimi P, Mehdizadeh M, Kr\u00fcger U, Hecht J, Mundlos S, Robinson PN (2014) First description of a patient with Vici syndrome due to a mutation affecting the penultimate exon of EPG5 and review of the literature. Am J Med Genet A 164(12):3170\u20133175","journal-title":"Am J Med Genet A"},{"key":"9078_CR139","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/8904_2017_71","volume":"42","author":"S Balasubramaniam","year":"2018","unstructured":"Balasubramaniam S, Riley LG, Vasudevan A, Cowley MJ, Gayevskiy V, Sue CM, Edwards C, Edkins E, Junckerstorff R, Kiraly-Borri C (2018) EPG5-related vici syndrome: a primary defect of autophagic regulation with an emerging phenotype overlapping with mitochondrial disorders. JIMD Reports 42:19\u201329","journal-title":"JIMD Reports"},{"issue":"2","key":"9078_CR140","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1002\/ajmg.a.34273","volume":"158","author":"E Said","year":"2012","unstructured":"Said E, Soler D, Sewry C (2012) Vici syndrome\u2014a rapidly progressive neurodegenerative disorder with hypopigmentation, immunodeficiency and myopathic changes on muscle biopsy. Am J Med Genet A 158(2):440\u2013444","journal-title":"Am J Med Genet A"},{"key":"9078_CR141","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1007\/s10875-020-00800-y","volume":"40","author":"B Al-Saud","year":"2020","unstructured":"Al-Saud B, Al Alawi Z, Hussain FB, Hershfield M, Alkuraya FS, Al-Mayouf SM (2020) A case with purine nucleoside phosphorylase deficiency suffering from late-onset systemic lupus erythematosus and lymphoma. J Clin Immunol 40:833\u2013839","journal-title":"J Clin Immunol"},{"issue":"2","key":"9078_CR142","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1203\/00006450-198702000-00006","volume":"21","author":"G Rijksen","year":"1987","unstructured":"Rijksen G, Kuis W, Wadman SK, Spaapen LJ, Duran M, Voorbrood B, Staal GE, Stoop JW, Zegers BJ (1987) A new case of purine nucleoside phosphorylase deficiency: enzymologic, clinical, and immunologic characteristics. Pediatr Res 21(2):137\u2013141","journal-title":"Pediatr Res"},{"issue":"5","key":"9078_CR143","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/j.jpeds.2004.06.075","volume":"145","author":"LA Myers","year":"2004","unstructured":"Myers LA, Hershfield MS, Neale WT, Escolar M, Kurtzberg J (2004) Purine nucleoside phosphorylase deficiency (PNP-def) presenting with lymphopenia and developmental delay: successful correction with umbilical cord blood transplantation. J Pediatr 145(5):710\u2013712","journal-title":"J Pediatr"},{"issue":"8","key":"9078_CR144","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1093\/brain\/awy173","volume":"141","author":"D Lessel","year":"2018","unstructured":"Lessel D, Gehbauer C, Bramswig NC, Schluth-Bolard C, Venkataramanappa S, Van Gassen KL, Hempel M, Haack TB, Baresic A, Genetti CA (2018) BCL11B mutations in patients affected by a neurodevelopmental disorder with reduced type 2 innate lymphoid cells. Brain 141(8):2299\u20132311","journal-title":"Brain"},{"issue":"8","key":"9078_CR145","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1016\/j.ajhg.2024.06.009","volume":"111","author":"D Rots","year":"2024","unstructured":"Rots D, Choufani S, Faundes V, Dingemans AJ, Joss S, Foulds N, Jones EA, Stewart S, Vasudevan P, Dabir T (2024) Pathogenic variants in KMT2C result in a neurodevelopmental disorder distinct from Kleefstra and Kabuki syndromes. The American Journal of Human Genetics 111(8):1626\u20131642","journal-title":"The American Journal of Human Genetics"},{"issue":"2","key":"9078_CR146","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1111\/jir.13100","volume":"68","author":"A Kalinousky","year":"2024","unstructured":"Kalinousky A, Rapp T, Harris J (2024) Attention challenges in Kabuki syndrome. J Intellect Disabil Res 68(2):173\u2013180","journal-title":"J Intellect Disabil Res"},{"key":"9078_CR147","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1007\/s10803-007-0433-x","volume":"38","author":"B Akin Sari","year":"2008","unstructured":"Akin Sari B, Karaer K, Bodur \u015e, Soysal A\u015e (2008) Case report: autistic disorder in Kabuki syndrome. J Autism Dev Disord 38:198\u2013201","journal-title":"J Autism Dev Disord"},{"issue":"9","key":"9078_CR148","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/s10038-024-01258-1","volume":"69","author":"J-H Yoon","year":"2024","unstructured":"Yoon J-H, Hwang S, Bae H, Kim D, Seo GH, Koh J-Y, Ju YS, Do H-S, Kim S, Kim G-H (2024) Clinical and molecular characteristics of Korean patients with Kabuki syndrome. J Hum Genet 69(9):417\u2013423","journal-title":"J Hum Genet"},{"issue":"10","key":"9078_CR149","doi-asserted-by":"publisher","first-page":"2976","DOI":"10.1002\/ajmg.a.62944","volume":"188","author":"E Usluer","year":"2022","unstructured":"Usluer E, Say\u0131n GY, G\u00fcne\u015f N, Kasap B, T\u00fcys\u00fcz B (2022) Investigation of genetic and phenotypic heterogeneity in 37 Turkish patients with Kabuki and Kabuki-like phenotype. Am J Med Genet A 188(10):2976\u20132987","journal-title":"Am J Med Genet A"},{"issue":"5","key":"9078_CR150","doi-asserted-by":"publisher","first-page":"e91","DOI":"10.1016\/j.oooo.2023.12.788","volume":"137","author":"LC Pinto","year":"2024","unstructured":"Pinto LC, Kokitsu-Nakata NM, da Silva DG, de Azevedo Silva LJ, de Almeida ALPF (2024) Systemic and oral abnormalities in Kabuki syndrome: a case series. Oral Surg Oral Med Oral Pathol Oral Radiol 137(5):e91\u2013e98","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"issue":"6","key":"9078_CR151","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1111\/jir.12597","volume":"63","author":"L van Dongen","year":"2019","unstructured":"van Dongen L, Wingberm\u00fchle P, van der Veld W, Stumpel C, Kleefstra T, Egger J (2019) Exploring the cognitive phenotype of Kabuki (Niikawa\u2013Kuroki) syndrome. J Intellect Disabil Res 63(6):498\u2013506","journal-title":"J Intellect Disabil Res"},{"issue":"7","key":"9078_CR152","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1038\/s41436-021-01119-8","volume":"23","author":"VM Fa\u00fandes G\u00f3mez","year":"2021","unstructured":"Fa\u00fandes G\u00f3mez VM, Goh S, Akilapa R, Bezuidenhout H, Bjornsson HT, Bradley L, Brady AF, Brischoux Boucher E, Brunner H, Bulk S (2021) Clinical delineation, sex differences, and genotype\u2013phenotype correlation in pathogenic KDM6A variants causing X-linked Kabuki syndrome type 2. Genet Med 23(7):1202\u20131210","journal-title":"Genet Med"},{"key":"9078_CR153","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1406781","volume":"15","author":"S Bhattad","year":"2024","unstructured":"Bhattad S, Ramakrishna SH, Kumar R, Choi JM, Markle JG (2024) Immune dysregulation due to bi-allelic mutation of the actin remodeling protein DIAPH1. Front Immunol 15","journal-title":"Front Immunol"},{"issue":"9","key":"9078_CR154","doi-asserted-by":"publisher","first-page":"e20220498","DOI":"10.1084\/jem.20220498","volume":"219","author":"FM Kaiser","year":"2022","unstructured":"Kaiser FM, Gruenbacher S, Oyaga MR, Nio E, Jaritz M, Sun Q, van der Zwaag W, Kreidl E, Zopf LM, Dalm VA (2022) Biallelic PAX5 mutations cause hypogammaglobulinemia, sensorimotor deficits, and autism spectrum disorder. J Exp Med 219(9):e20220498","journal-title":"J Exp Med"},{"key":"9078_CR155","doi-asserted-by":"publisher","first-page":"100377","DOI":"10.1016\/j.bbih.2021.100377","volume":"18","author":"I Serra","year":"2021","unstructured":"Serra I, Manusama OR, Kaiser FM, Floriano II, Wahl L, van der Zalm C, Ijspeert H, van Hagen PM, van Beveren NJ, Arend SM (2021) Activated PI3K\u03b4 syndrome, an immunodeficiency disorder, leads to sensorimotor deficits recapitulated in a murine model. Brain, Behavior, & Immunity-Health 18:100377","journal-title":"Brain, Behavior, & Immunity-Health"},{"issue":"2","key":"9078_CR156","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.jaci.2016.06.021","volume":"139","author":"TI Coulter","year":"2017","unstructured":"Coulter TI, Chandra A, Bacon CM, Babar J, Curtis J, Screaton N, Goodlad JR, Farmer G, Steele CL, Leahy TR (2017) Clinical spectrum and features of activated phosphoinositide 3-kinase \u03b4 syndrome: a large patient cohort study. Journal of Allergy and Clinical Immunology 139(2):597\u2013606 (e594)","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"11","key":"9078_CR157","first-page":"4095","volume":"9","author":"J Oh","year":"2021","unstructured":"Oh J, Garabedian E, Fuleihan R (2021) Cunningham-Rundles C: Clinical manifestations and outcomes of activated phosphoinositide 3-kinase \u03b4 syndrome from the USIDNET cohort. The Journal of Allergy and Clinical Immunology 9(11):4095\u20134102 (In Practice)","journal-title":"The Journal of Allergy and Clinical Immunology"},{"issue":"1","key":"9078_CR158","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.jaci.2016.03.022","volume":"138","author":"E Elkaim","year":"2016","unstructured":"Elkaim E, Neven B, Bruneau J, Mitsui-Sekinaka K, Stanislas A, Heurtier L, Lucas CL, Matthews H, Deau M-C, Sharapova S (2016) Clinical and immunologic phenotype associated with activated phosphoinositide 3-kinase \u03b4 syndrome 2: a cohort study. Journal of Allergy and Clinical Immunology 138(1):210\u2013218 (e219)","journal-title":"Journal of Allergy and Clinical Immunology"},{"key":"9078_CR159","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2021.688022","volume":"9","author":"N Moreno-Corona","year":"2021","unstructured":"Moreno-Corona N, Chentout L, Poggi L, Thouenon R, Masson C, Parisot M, Mouel LL, Picard C, Andr\u00e9 I, Cavazzana M (2021) Two monogenetic disorders, activated PI3-Kinase-\u03b4 syndrome 2 and Smith-Magenis syndrome, in one patient: case report and a literature review of neurodevelopmental impact in primary immunodeficiencies associated with disturbed PI3K signaling. Front Pediatr 9","journal-title":"Front Pediatr"},{"issue":"3","key":"9078_CR160","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1556\/amicr.59.2012.3.4","volume":"59","author":"I Mohammadzadeh","year":"2012","unstructured":"Mohammadzadeh I, Yeganeh M, Khaledi M, Salehiomran M, Aghamohammadi A, Rezaei N (2012) Debilitating progressive encephalitis in a patient with BTK deficiency. Acta Microbiol Immunol Hung 59(3):335\u2013342","journal-title":"Acta Microbiol Immunol Hung"},{"issue":"8","key":"9078_CR161","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/jhg.2011.61","volume":"56","author":"T Arai","year":"2011","unstructured":"Arai T, Zhao M, Kanegane H, Van Zelm MC, Futatani T, Yamada M, Ariga T, Ochs HD, Miyawaki T, Oh-Ishi T (2011) Genetic analysis of contiguous X-chromosome deletion syndrome encompassing the BTK and TIMM8A genes. J Hum Genet 56(8):577\u2013582","journal-title":"J Hum Genet"},{"key":"9078_CR162","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.897975","volume":"13","author":"C Franco-Jarava","year":"2022","unstructured":"Franco-Jarava C, Valenzuela I, Riviere JG, Garcia-Prat M, Mart\u00ednez-Gallo M, Dieli-Crimi R, Castells N, Batlle-Mas\u00f3 L, Soler-Palacin P, Colobran R (2022) Common variable immunodeficiency and neurodevelopmental delay due to a 13Mb deletion on chromosome 4 including the NFKB1 gene: a case report. Front Immunol 13","journal-title":"Front Immunol"},{"issue":"8","key":"9078_CR163","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1007\/s10875-023-01584-7","volume":"43","author":"F Saettini","year":"2023","unstructured":"Saettini F, Guerra F, Fazio G, Bugarin C, McMillan HJ, Ohtake A, Ardissone A, Itoh M, Giglio S, Cappuccio G (2023) Antibody deficiency in patients with biallelic KARS1 mutations. J Clin Immunol 43(8):2115\u20132125","journal-title":"J Clin Immunol"},{"issue":"21","key":"9078_CR164","doi-asserted-by":"publisher","DOI":"10.12998\/wjcc.v10.i21.7397","volume":"10","author":"K Abuduxikuer","year":"2022","unstructured":"Abuduxikuer K, Wang L, Zou L, Cao C-Y, Yu L, Guo H-M, Liang X-M, Wang J-S, Chen L (2022) Updated clinical and glycomic features of mannosyl-oligosaccharide glucosidase deficiency: two case reports. World Journal of Clinical Cases 10(21)","journal-title":"World Journal of Clinical Cases"},{"issue":"8","key":"9078_CR165","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1007\/s00439-022-02506-0","volume":"142","author":"A Frohne","year":"2023","unstructured":"Frohne A, Koenighofer M, Cetin H, Nieratschker M, Liu DT, Laccone F, Neesen J, Nemec SF, Schwarz-Nemec U, Schoefer C (2023) A homozygous AP3D1 missense variant in patients with sensorineural hearing loss as the leading manifestation. Hum Genet 142(8):1077\u20131089","journal-title":"Hum Genet"},{"issue":"1","key":"9078_CR166","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1182\/blood-2005-01-0319","volume":"106","author":"M Tardieu","year":"2005","unstructured":"Tardieu M, Lacroix C, Neven Bnd, Bordigoni P, Basile GvdS, Blanche Sp, Fischer A (2005) Progressive neurologic dysfunctions 20 years after allogeneic bone marrow transplantation for Chediak-Higashi syndrome. Blood 106(1):40\u201342","journal-title":"Blood"},{"issue":"9","key":"9078_CR167","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1001\/archneur.1984.04050200111031","volume":"41","author":"RE Pettit","year":"1984","unstructured":"Pettit RE, Berdal KG (1984) Chediak-Higashi syndrome: neurologic appearance. Arch Neurol 41(9):1001\u20131002","journal-title":"Arch Neurol"},{"issue":"4","key":"9078_CR168","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1001\/archneur.1971.00490040015001","volume":"25","author":"W Sheramata","year":"1971","unstructured":"Sheramata W, Kott HS, Cyr DP (1971) The Chediak-Higashi-Steinbrinck syndrome: presentation of three cases with features resembling spinocerebellar degeneration. Arch Neurol 25(4):289\u2013294","journal-title":"Arch Neurol"},{"issue":"3","key":"9078_CR169","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1111\/j.1600-0404.1994.tb01657.x","volume":"89","author":"E Uyama","year":"1994","unstructured":"Uyama E, Hirano T, Ito K, Nakashima H, Sugimoto M, Naito M, Uchino M, Ando M (1994) Adult Ch\u00e9diak-Higashi syndrome presenting as parkinsonism and dementia. Acta Neurol Scand 89(3):175\u2013183","journal-title":"Acta Neurol Scand"},{"issue":"4","key":"9078_CR170","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1002\/1531-8257(200007)15:4<705::AID-MDS1016>3.0.CO;2-B","volume":"15","author":"RA Hauser","year":"2000","unstructured":"Hauser RA, Friedlander J, Baker MJ, Thomas J, Zuckerman KS (2000) Adult Chediak-Higashi parkinsonian syndrome with dystonia. Movement Disorders: Official Journal of the Movement Disorder Society 15(4):705\u2013708","journal-title":"Movement Disorders: Official Journal of the Movement Disorder Society"},{"issue":"6","key":"9078_CR171","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/S0022-3476(67)80267-1","volume":"70","author":"LA Lockman","year":"1967","unstructured":"Lockman LA, Kennedy WR, White JG (1967) The Chediak-Higashi syndrome: electrophysiological and electron microscopic observations on the peripheral neuropathy. J Pediatr 70(6):942\u2013951","journal-title":"J Pediatr"},{"issue":"3","key":"9078_CR172","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.jpeds.2009.09.026","volume":"156","author":"EN Kerr","year":"2010","unstructured":"Kerr EN, Ellis L, Dupuis A, Rommens JM, Durie PR (2010) The behavioral phenotype of school-age children with shwachman diamond syndrome indicates neurocognitive dysfunction with loss of Shwachman-Bodian-Diamond syndrome gene function. The Journal of pediatrics 156(3):433\u2013438 (e431)","journal-title":"The Journal of pediatrics"},{"issue":"3","key":"9078_CR173","first-page":"265","volume":"29","author":"M Cipolli","year":"1999","unstructured":"Cipolli M, D\u2019Orazio C, Delmarco A, Marchesini C, Miano A, Mastella G (1999) Shwachman\u2019s syndrome: pathomorphosis and long-term outcome. J Pediatr Gastroenterol Nutr 29(3):265\u2013272","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"05","key":"9078_CR174","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1055\/s-2008-1062704","volume":"38","author":"N Rezaei","year":"2007","unstructured":"Rezaei N, Chavoshzadeh Z, Alaei O, Sandrock I, Klein C (2007) Association of HAX1 deficiency with neurological disorder. Neuropediatrics 38(05):261\u2013263","journal-title":"Neuropediatrics"},{"issue":"12","key":"9078_CR175","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1136\/jmg.2008.058297","volume":"45","author":"N Ishikawa","year":"2008","unstructured":"Ishikawa N, Okada S, Miki M, Shirao K, Kihara H, Tsumura M, Nakamura K, Kawaguchi H, Ohtsubo M, Yasunaga Si (2008) Neurodevelopmental abnormalities associated with severe congenital neutropenia due to the R86X mutation in the HAX1 gene. Journal of medical genetics 45(12):802\u2013807","journal-title":"Journal of medical genetics"},{"issue":"1","key":"9078_CR176","doi-asserted-by":"publisher","first-page":"9686","DOI":"10.1038\/s41598-022-13717-w","volume":"12","author":"M Zorn","year":"2022","unstructured":"Zorn M, K\u00fchnisch J, Bachmann S, Seifert W (2022) Disease relevance of rare VPS13B missense variants for neurodevelopmental Cohen syndrome. Sci Rep 12(1):9686","journal-title":"Sci Rep"},{"key":"9078_CR177","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.jpeds.2022.08.052","volume":"252","author":"N G\u00fcne\u015f","year":"2023","unstructured":"G\u00fcne\u015f N, Alkaya DU, Demirbilek V, Yal\u00e7\u0131nkaya C, T\u00fcys\u00fcz B (2023) Early diagnostic signs and the natural history of typical findings in Cohen syndrome. J Pediatr 252:93\u2013100","journal-title":"J Pediatr"},{"issue":"1","key":"9078_CR178","doi-asserted-by":"publisher","first-page":"e147","DOI":"10.1097\/WNO.0000000000001249","volume":"42","author":"R Huna-Baron","year":"2022","unstructured":"Huna-Baron R, Yahalom G, Anikster Y, Zeev BB, Hoffmann C, Hassin-Baer S (2022) Neuro-ophthalmic phenotype of OPA3. J Neuroophthalmol 42(1):e147\u2013e152","journal-title":"J Neuroophthalmol"},{"issue":"9","key":"9078_CR179","doi-asserted-by":"publisher","first-page":"2446","DOI":"10.1002\/ajmg.a.63310","volume":"191","author":"EA Werren","year":"2023","unstructured":"Werren EA, Srinivasan VM, Gowda VK, Pandey A, Vaish S, Kabbur AR, Nandeesh BN, Srivastava A (2023) A novel biallelic frameshift variant in C2orf69 causing developmental regression, seizures, microcephaly, autistic features, and hypertonia. Am J Med Genet A 191(9):2446\u20132450","journal-title":"Am J Med Genet A"},{"issue":"4","key":"9078_CR180","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1111\/jns.12409","volume":"25","author":"D Vaughan","year":"2020","unstructured":"Vaughan D, Bogdanova-Mihaylova P, Costello DJ, Sweeney BJ, McNamara B, Walsh RA, Murphy SM (2020) Ataxia pancytopenia syndrome due to SAMD9L mutation presenting as demyelinating neuropathy. J Peripher Nerv Syst 25(4):433\u2013437","journal-title":"J Peripher Nerv Syst"},{"issue":"3","key":"9078_CR181","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1002\/(SICI)1096-8628(20000131)90:3<252::AID-AJMG14>3.0.CO;2-V","volume":"90","author":"AGd Angel","year":"2000","unstructured":"Angel AGd, Cervera M, Gomez L, P\u00e9rez-Vera P, Orozco L, Carnevale A, Del Castillo V (2000) Ataxia-pancytopenia syndrome. Am J Med Genet 90(3):252\u2013254","journal-title":"Am J Med Genet"},{"issue":"5","key":"9078_CR182","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.ajhg.2009.04.010","volume":"84","author":"R Waltes","year":"2009","unstructured":"Waltes R, Kalb R, Gatei M, Kijas AW, Stumm M, Sobeck A, Wieland B, Varon R, Lerenthal Y, Lavin MF (2009) Human RAD50 deficiency in a Nijmegen breakage syndrome-like disorder. The American Journal of Human Genetics 84(5):605\u2013616","journal-title":"The American Journal of Human Genetics"},{"issue":"6","key":"9078_CR183","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1002\/ajmg.a.61570","volume":"182","author":"A Ragamin","year":"2020","unstructured":"Ragamin A, Yigit G, Bousset K, Beleggia F, Verheijen FW, de Wit MCY, Strom TM, D\u00f6rk T, Wollnik B, Mancini GM (2020) Human RAD50 deficiency: confirmation of a distinctive phenotype. Am J Med Genet A 182(6):1378\u20131386","journal-title":"Am J Med Genet A"},{"key":"9078_CR184","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11882-018-0823-5","volume":"18","author":"CY Kuo","year":"2018","unstructured":"Kuo CY, Signer R, Saitta SC (2018) Immune and genetic features of the chromosome 22q11. 2 deletion (DiGeorge syndrome). Current Allergy and Asthma Reports 18:1\u20137","journal-title":"Current Allergy and Asthma Reports"},{"issue":"2","key":"9078_CR185","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/s41380-024-02661-y","volume":"30","author":"RC Gur","year":"2025","unstructured":"Gur RC, Bearden CE, Jacquemont S, Swillen A, van Amelsvoort T, van den Bree M, Vorstman J, Sebat J, Ruparel K, Gallagher RS (2025) Neurocognitive profiles of 22q11. 2 and 16p11. 2 deletions and duplications. Molecular Psychiatry 30(2):379\u2013387","journal-title":"Molecular Psychiatry"},{"issue":"5","key":"9078_CR186","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1093\/hmg\/ddm341","volume":"17","author":"B Jin","year":"2008","unstructured":"Jin B, Tao Q, Peng J, Soo HM, Wu W, Ying J, Fields CR, Delmas AL, Liu X, Qiu J (2008) DNA methyltransferase 3B (DNMT3B) mutations in ICF syndrome lead to altered epigenetic modifications and aberrant expression of genes regulating development, neurogenesis and immune function. Hum Mol Genet 17(5):690\u2013709","journal-title":"Hum Mol Genet"},{"key":"9078_CR187","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13023-016-0543-7","volume":"11","author":"C Rothblum-Oviatt","year":"2016","unstructured":"Rothblum-Oviatt C, Wright J, Lefton-Greif MA, McGrath-Morrow SA, Crawford TO, Lederman HM (2016) Ataxia telangiectasia: a review. Orphanet J Rare Dis 11:1\u201321","journal-title":"Orphanet J Rare Dis"},{"issue":"12","key":"9078_CR188","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1038\/s41580-021-00394-2","volume":"22","author":"J-H Lee","year":"2021","unstructured":"Lee J-H, Paull TT (2021) Cellular functions of the protein kinase ATM and their relevance to human disease. Nat Rev Mol Cell Biol 22(12):796\u2013814","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"16","key":"9078_CR189","doi-asserted-by":"publisher","first-page":"16479","DOI":"10.1074\/jbc.M312796200","volume":"279","author":"A L\u00e4hdesm\u00e4ki","year":"2004","unstructured":"L\u00e4hdesm\u00e4ki A, Taylor AMR, Chrzanowska KH, Pan-Hammarstr\u00f6m Q (2004) Delineation of the role of the Mre11 complex in class switch recombination. J Biol Chem 279(16):16479\u201316487","journal-title":"J Biol Chem"},{"issue":"4","key":"9078_CR190","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1080\/15548627.2024.2431472","volume":"21","author":"Q Liu","year":"2025","unstructured":"Liu Q, Wang X, Fang ZT, Zhao JN, Rui XX, Zhang BG, He Y, Liu RJ, Chen J, Chai GS, Liu GP (2025) Upregulation of ISG15 induced by MAPT\/tau accumulation represses autophagic flux by inhibiting HDAC6 activity: a vicious cycle in Alzheimer disease. Autophagy 21(4):807\u2013826","journal-title":"Autophagy"},{"issue":"6","key":"9078_CR191","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.ejpn.2015.07.001","volume":"19","author":"B Ben-Zeev","year":"2015","unstructured":"Ben-Zeev B, Tabib A, Nissenkorn A, Garti B-Z, Gomori JM, Nass D, Goldshmidt H, Fellig Y, Anikster Y, Nevo Y (2015) Devastating recurrent brain ischemic infarctions and retinal disease in pediatric patients with CD59 deficiency. Eur J Paediatr Neurol 19(6):688\u2013693","journal-title":"Eur J Paediatr Neurol"},{"issue":"2","key":"9078_CR192","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.tins.2013.11.002","volume":"37","author":"N Marchi","year":"2014","unstructured":"Marchi N, Granata T, Janigro D (2014) Inflammatory pathways of seizure disorders. Trends Neurosci 37(2):55\u201365","journal-title":"Trends Neurosci"},{"issue":"5","key":"9078_CR193","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.tips.2020.02.004","volume":"41","author":"C Alam","year":"2020","unstructured":"Alam C, Kondo M, O\u2019Connor DL, Bendayan R (2020) Clinical implications of folate transport in the central nervous system. Trends Pharmacol Sci 41(5):349\u2013361","journal-title":"Trends Pharmacol Sci"},{"issue":"1","key":"9078_CR194","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s41936-020-00148-0","volume":"81","author":"A Nawaz","year":"2020","unstructured":"Nawaz A, Khattak NN, Khan MS, Nangyal H, Sabri S, Shakir M (2020) Deficiency of vitamin B12 and its relation with neurological disorders: a critical review. The Journal of Basic and Applied Zoology 81(1):10","journal-title":"The Journal of Basic and Applied Zoology"},{"key":"9078_CR195","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1007\/s10875-016-0336-8","volume":"36","author":"JT-U Nguyen","year":"2016","unstructured":"Nguyen JT-U, Green A, Wilson MR, DeRisi JL, Gundling K (2016) Neurologic complications of common variable immunodeficiency. Journal of Clinical Immunology 36:793\u2013800","journal-title":"Journal of Clinical Immunology"},{"issue":"3","key":"9078_CR196","volume":"10","author":"BI De Almeida","year":"2023","unstructured":"De Almeida BI, Smith TL, Delic A, Esquibel L, Galli J, Millsap L, Paz Sold\u00e1n MM, Cortez MM, Rose J, Greenlee JE (2023) Neurologic manifestations of common variable immunodeficiency: impact on quality of life. Neurology: Neuroimmunology and Neuroinflammation 10(3)","journal-title":"Neurology: Neuroimmunology and Neuroinflammation"},{"issue":"4","key":"9078_CR197","volume":"7","author":"X Ayrignac","year":"2020","unstructured":"Ayrignac X, Goulabchand R, Jeziorski E, Rullier P, Carra-Dalli\u00e8re C, Lozano C, Portales P, Vincent T, Viallard JF, Menjot de Champfleur N (2020) Two neurologic facets of CTLA4-related haploinsufficiency. Neurology: Neuroimmunology and Neuroinflammation 7(4)","journal-title":"Neurology: Neuroimmunology and Neuroinflammation"},{"issue":"1","key":"9078_CR198","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1186\/s12887-023-04182-z","volume":"23","author":"T Mangodt","year":"2023","unstructured":"Mangodt T, Vanden Driessche K, Norga K, Moes N, De Bruyne M, Haerynck F, Bordon V, Jansen A, Jonckheere A (2023) Central nervous system manifestations of LRBA deficiency: case report of two siblings and literature review. BMC Pediatr 23(1):353","journal-title":"BMC Pediatr"},{"issue":"1","key":"9078_CR199","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/s41572-019-0113-0","volume":"5","author":"AMR Taylor","year":"2019","unstructured":"Taylor AMR, Rothblum-Oviatt C, Ellis NA, Hickson ID, Meyer S, Crawford TO, Smogorzewska A, Pietrucha B, Weemaes C, Stewart GS (2019) Chromosome instability syndromes. Nat Rev Dis Primers 5(1):64","journal-title":"Nat Rev Dis Primers"},{"issue":"11","key":"9078_CR200","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1016\/j.dnarep.2007.06.011","volume":"6","author":"E Gorodetsky","year":"2007","unstructured":"Gorodetsky E, Calkins S, Ahn J, Brooks P (2007) ATM, the Mre11\/Rad50\/Nbs1 complex, and topoisomerase I are concentrated in the nucleus of Purkinje neurons in the juvenile human brain. DNA Repair 6(11):1698\u20131707","journal-title":"DNA Repair"},{"key":"9078_CR201","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13023-016-0520-1","volume":"11","author":"T Altmann","year":"2016","unstructured":"Altmann T, Gennery AR (2016) DNA ligase IV syndrome; a review. Orphanet J Rare Dis 11:1\u20137","journal-title":"Orphanet J Rare Dis"},{"key":"9078_CR202","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1750-1172-7-13","volume":"7","author":"KH Chrzanowska","year":"2012","unstructured":"Chrzanowska KH, Gregorek H, Dembowska-Bagi\u0144ska B, Kalina MA, Digweed M (2012) Nijmegen breakage syndrome (NBS). Orphanet J Rare Dis 7:1\u201319","journal-title":"Orphanet J Rare Dis"},{"key":"9078_CR203","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11882-020-00955-z","volume":"20","author":"MA Slatter","year":"2020","unstructured":"Slatter MA, Gennery AR (2020) Update on DNA-double strand break repair defects in combined primary immunodeficiency. Curr Allergy Asthma Rep 20:1\u201312","journal-title":"Curr Allergy Asthma Rep"},{"issue":"9","key":"9078_CR204","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1002\/humu.21315","volume":"31","author":"V Dutrannoy","year":"2010","unstructured":"Dutrannoy V, Demuth I, Baumann U, Schindler D, Konrat K, Neitzel H, Gillessen-Kaesbach G, Radszewski J, Rothe S, Schellenberger MT (2010) Clinical variability and novel mutations in the NHEJ1 gene in patients with a Nijmegen breakage syndrome-like phenotype. Hum Mutat 31(9):1059\u20131068","journal-title":"Hum Mutat"},{"issue":"3","key":"9078_CR205","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1002\/ajmg.a.30869","volume":"137","author":"TI Ben-Omran","year":"2005","unstructured":"Ben-Omran TI, Cerosaletti K, Concannon P, Weitzman S, Nezarati MM (2005) A patient with mutations in DNA Ligase IV: clinical features and overlap with Nijmegen breakage syndrome. Am J Med Genet A 137(3):283\u2013287","journal-title":"Am J Med Genet A"},{"issue":"6","key":"9078_CR206","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1016\/S1097-2765(01)00408-7","volume":"8","author":"M O'Driscoll","year":"2001","unstructured":"O\u2019Driscoll M, Cerosaletti KM, Girard P-M, Dai Y, Stumm M, Kysela B, Hirsch B, Gennery A, Palmer SE, Seidel J (2001) DNA ligase IV mutations identified in patients exhibiting developmental delay and immunodeficiency. Mol Cell 8(6):1175\u20131185","journal-title":"Mol Cell"},{"issue":"S1","key":"9078_CR207","doi-asserted-by":"publisher","first-page":"S71","DOI":"10.1002\/eji.200737396","volume":"37","author":"P Rivera-Munoz","year":"2007","unstructured":"Rivera-Munoz P, Malivert L, Derdouch S, Azerrad C, Abramowski V, Revy P (2007) Villartay JPd: DNA repair and the immune system: from V (D) J recombination to aging lymphocytes. Eur J Immunol 37(S1):S71\u2013S82","journal-title":"Eur J Immunol"},{"issue":"2","key":"9078_CR208","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.neuron.2014.06.034","volume":"83","author":"R Madabhushi","year":"2014","unstructured":"Madabhushi R, Pan L, Tsai L-H (2014) DNA damage and its links to neurodegeneration. Neuron 83(2):266\u2013282","journal-title":"Neuron"},{"issue":"12","key":"9078_CR209","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1038\/s41423-023-01106-w","volume":"20","author":"Z Ying","year":"2023","unstructured":"Ying Z, Hardikar S, Plummer JB, Hamidi T, Liu B, Chen Y, Shen J, Mu Y, McBride KM, Chen T (2023) Enhanced CD19 activity in B cells contributes to immunodeficiency in mice deficient in the ICF syndrome gene Zbtb24. Cell Mol Immunol 20(12):1487\u20131498","journal-title":"Cell Mol Immunol"},{"issue":"6","key":"9078_CR210","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1042\/EBC20190035","volume":"63","author":"M Vukic","year":"2019","unstructured":"Vukic M, Daxinger L (2019) DNA methylation in disease: immunodeficiency, centromeric instability, facial anomalies syndrome. Essays Biochem 63(6):773\u2013783","journal-title":"Essays Biochem"},{"issue":"1","key":"9078_CR211","doi-asserted-by":"publisher","first-page":"5702","DOI":"10.1038\/s41467-021-25846-3","volume":"12","author":"NC Reddy","year":"2021","unstructured":"Reddy NC, Majidi SP, Kong L, Nemera M, Ferguson CJ, Moore M, Goncalves TM, Liu H-K, Fitzpatrick JA, Zhao G (2021) CHARGE syndrome protein CHD7 regulates epigenomic activation of enhancers in granule cell precursors and gyrification of the cerebellum. Nat Commun 12(1):5702","journal-title":"Nat Commun"},{"key":"9078_CR212","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1750-1172-1-34","volume":"1","author":"KD Blake","year":"2006","unstructured":"Blake KD, Prasad C (2006) CHARGE syndrome. Orphanet J Rare Dis 1:1\u20138","journal-title":"Orphanet J Rare Dis"},{"issue":"4","key":"9078_CR213","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/sj.ejhg.5201778","volume":"15","author":"D Sanlaville","year":"2007","unstructured":"Sanlaville D, Verloes A (2007) CHARGE syndrome: an update. Eur J Hum Genet 15(4):389\u2013399","journal-title":"Eur J Hum Genet"},{"key":"9078_CR214","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1038\/s41590-024-01997-5","volume":"25","author":"K Okuyama","year":"2024","unstructured":"Okuyama K, Yamashita M, Koumoundourou A et al (2024) A mutant BCL11B-N440K protein interferes with BCL11A function during T lymphocyte and neuronal development. Nat Immunol 25:2284\u20132296. https:\/\/doi.org\/10.1038\/s41590-024-01997-5","journal-title":"Nat Immunol"},{"issue":"3","key":"9078_CR215","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/s41435-024-00263-w","volume":"25","author":"JM Garc\u00eda-Aznar","year":"2024","unstructured":"Garc\u00eda-Aznar JM, Alonso Alvarez S, Bernal del Castillo T (2024) Pivotal role of BCL11B in the immune, hematopoietic and nervous systems: a review of the BCL11B-associated phenotypes from the genetic perspective. Genes Immun 25(3):232\u2013241","journal-title":"Genes Immun"},{"issue":"22","key":"9078_CR216","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1056\/NEJMoa1509164","volume":"375","author":"D Punwani","year":"2016","unstructured":"Punwani D, Zhang Y, Yu J, Cowan MJ, Rana S, Kwan A, Adhikari AN, Lizama CO, Mendelsohn BA, Fahl SP (2016) Multisystem anomalies in severe combined immunodeficiency with mutant BCL11B. N Engl J Med 375(22):2165\u20132176","journal-title":"N Engl J Med"},{"key":"9078_CR217","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2023.1087002","volume":"11","author":"L Leonardi","year":"2023","unstructured":"Leonardi L, Testa A, Feleppa M, Paparella R, Conti F, Marzollo A, Spalice A, Giona F, Gnazzo M, Andreoli GM (2023) Immune dysregulation in Kabuki syndrome: a case report of Evans syndrome and hypogammaglobulinemia. Front Pediatr 11","journal-title":"Front Pediatr"},{"key":"9078_CR218","doi-asserted-by":"publisher","first-page":"1402531","DOI":"10.3389\/fgene.2024.1402531","volume":"15","author":"S Boniel","year":"2024","unstructured":"Boniel S, Krajewska M, Pyr\u017cak B, Paluchowska M, Majcher A, Zarlenga M, Krenke K, \u015amigiel R, Jeziorek A, Szyma\u0144ska K (2024) Clinical and molecular characteristics of Kabuki syndrome patients with missense variants\u2014novel features and literature review. Front Genet 15:1402531","journal-title":"Front Genet"},{"key":"9078_CR219","doi-asserted-by":"crossref","unstructured":"Bjornsson HT, Benjamin JS, Zhang L, Weissman J, Gerber EE, Chen Y-C, Vaurio RG, Potter MC, Hansen KD, Dietz HC (2014) Histone deacetylase inhibition rescues structural and functional brain deficits in a mouse model of Kabuki syndrome. Sci Transl Med 6(256):256ra135\u2013256ra135","DOI":"10.1126\/scitranslmed.3009278"},{"key":"9078_CR220","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1007\/s10875-020-00808-4","volume":"40","author":"F Saettini","year":"2020","unstructured":"Saettini F, Herriot R, Prada E, Nizon M, Zama D, Marzollo A, Romaniouk I, Lougaris V, Cortesi M, Morreale A (2020) Prevalence of immunological defects in a cohort of 97 Rubinstein-Taybi syndrome patients. J Clin Immunol 40:851\u2013860","journal-title":"J Clin Immunol"},{"key":"9078_CR221","doi-asserted-by":"publisher","first-page":"314","DOI":"10.3389\/fimmu.2016.00314","volume":"7","author":"KV Whitmore","year":"2016","unstructured":"Whitmore KV, Gaspar HB (2016) Adenosine deaminase deficiency\u2013more than just an immunodeficiency. Front Immunol 7:314","journal-title":"Front Immunol"},{"issue":"6","key":"9078_CR222","first-page":"1665","volume":"11","author":"E Grunebaum","year":"2023","unstructured":"Grunebaum E, Booth C, Cuvelier GD, Loves R, Aiuti A, Kohn DB (2023) Updated management guidelines for adenosine deaminase deficiency. The Journal of Allergy and Clinical Immunology 11(6):1665\u20131675 (In Practice)","journal-title":"The Journal of Allergy and Clinical Immunology"},{"issue":"5","key":"9078_CR223","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/S1474-4422(12)70040-6","volume":"11","author":"HH Freeze","year":"2012","unstructured":"Freeze HH, Eklund EA, Ng BG, Patterson MC (2012) Neurology of inherited glycosylation disorders. The Lancet Neurology 11(5):453\u2013466","journal-title":"The Lancet Neurology"},{"key":"9078_CR224","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13023-016-0399-x","volume":"11","author":"S Byrne","year":"2016","unstructured":"Byrne S, Dionisi-Vici C, Smith L, Gautel M, Jungbluth H (2016) Vici syndrome: a review. Orphanet J Rare Dis 11:1\u20139","journal-title":"Orphanet J Rare Dis"},{"key":"9078_CR225","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s00401-014-1361-4","volume":"129","author":"M Damme","year":"2015","unstructured":"Damme M, Suntio T, Saftig P, Eskelinen E-L (2015) Autophagy in neuronal cells: general principles and physiological and pathological functions. Acta Neuropathol 129:337\u2013362","journal-title":"Acta Neuropathol"},{"issue":"14","key":"9078_CR226","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1212\/WNL.0000000000002551","volume":"86","author":"WJ Introne","year":"2016","unstructured":"Introne WJ, Westbroek W, Cullinane AR, Groden CA, Bhambhani V, Golas GA, Baker EH, Lehky TJ, Snow J, Ziegler SG (2016) Neurologic involvement in patients with atypical Chediak-Higashi disease. Neurology 86(14):1320\u20131328","journal-title":"Neurology"},{"key":"9078_CR227","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.ddmod.2019.10.008","volume":"31","author":"P Sharma","year":"2020","unstructured":"Sharma P, Nicoli E-R, Serra-Vinardell J, Morimoto M, Toro C, Malicdan MCV, Introne WJ (2020) Chediak-Higashi syndrome: a review of the past, present, and future. Drug Discov Today Dis Model 31:31\u201336","journal-title":"Drug Discov Today Dis Model"},{"key":"9078_CR228","doi-asserted-by":"crossref","unstructured":"McDonald-McGinn DM, Sullivan KE, Marino B, Philip N, Swillen A, Vorstman JA, Zackai EH, Emanuel BS, Vermeesch JR, Morrow BE (2015) 22q11. 2 deletion syndrome. Nat Rev Dis Prim 1(1):1\u201319","DOI":"10.1038\/nrdp.2015.71"},{"issue":"4","key":"9078_CR229","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s11882-023-01071-4","volume":"23","author":"SE Biggs","year":"2023","unstructured":"Biggs SE, Gilchrist B, May KR (2023) Chromosome 22q11. 2 deletion (DiGeorge syndrome): immunologic features, diagnosis, and management. Current Allergy and Asthma Reports 23(4):213\u2013222","journal-title":"Current Allergy and Asthma Reports"},{"issue":"4","key":"9078_CR230","doi-asserted-by":"publisher","first-page":"274","DOI":"10.20517\/jtgg.2023.32","volume":"7","author":"H Jyonouchi","year":"2023","unstructured":"Jyonouchi H (2023) Inborn errors of immunity present with neuropsychiatric symptoms overlapping with autistic behavioral symptoms. Journal of Translational Genetics and Genomics 7(4):274\u2013290","journal-title":"Journal of Translational Genetics and Genomics"},{"issue":"3","key":"9078_CR231","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s12016-024-08996-2","volume":"66","author":"B Hom","year":"2024","unstructured":"Hom B, Boyd NK, Vogel BN, Nishimori N, Khoshnood MM, Jafarpour S, Nagesh D, Santoro JD (2024) Down syndrome and autoimmune disease. Clin Rev Allergy Immunol 66(3):261\u2013273","journal-title":"Clin Rev Allergy Immunol"},{"key":"9078_CR232","doi-asserted-by":"crossref","unstructured":"Lee-Kirsch MA, Wolf C, Kretschmer S, Roers A (2015) Type I interferonopathies\u2014an expanding disease spectrum of immunodysregulation. In: Seminars in immunopathology: 2015: Springer, pp 349\u2013357","DOI":"10.1007\/s00281-015-0500-x"},{"issue":"7","key":"9078_CR233","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1007\/s12519-022-00679-2","volume":"19","author":"GB Dell\u2019Isola","year":"2023","unstructured":"Dell\u2019Isola GB, Dini G, Culpepper KL, Portwood KE, Ferrara P, Di Cara G, Verrotti A, Lodolo M (2023) Clinical spectrum and currently available treatment of type I interferonopathy Aicardi-Gouti\u00e8res syndrome. World Journal of Pediatrics 19(7):635\u2013643","journal-title":"World Journal of Pediatrics"},{"issue":"6","key":"9078_CR234","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/nrn3880","volume":"16","author":"FL Heppner","year":"2015","unstructured":"Heppner FL, Ransohoff RM, Becher B (2015) Immune attack: the role of inflammation in Alzheimer disease. Nat Rev Neurosci 16(6):358\u2013372","journal-title":"Nat Rev Neurosci"},{"issue":"11","key":"9078_CR235","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1016\/S1474-4422(24)00263-1","volume":"23","author":"YJ Crow","year":"2024","unstructured":"Crow YJ (2024) CNS disease associated with enhanced type I interferon signalling. Lancet Neurol 23(11):1158\u20131168","journal-title":"Lancet Neurol"},{"issue":"2","key":"9078_CR236","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/S1525-1578(10)60493-X","volume":"6","author":"MS Lim","year":"2004","unstructured":"Lim MS, Elenitoba-Johnson KS (2004) The molecular pathology of primary immunodeficiencies. Journal of Molecular Diagnostics: JMD 6(2):59","journal-title":"Journal of Molecular Diagnostics: JMD"},{"key":"9078_CR237","doi-asserted-by":"crossref","unstructured":"Schulert GS, Zhang K (2024) Genetics of acquired cytokine storm syndromes: secondary HLH genetics. Cytokine Storm Syndrome. Adv Exp Med Biol 1448:103-119","DOI":"10.1007\/978-3-031-59815-9_8"},{"key":"9078_CR238","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.827815","volume":"12","author":"H Lindahl","year":"2022","unstructured":"Lindahl H, Bryceson YT (2022) Neuroinflammation associated with inborn errors of immunity. Front Immunol 12","journal-title":"Front Immunol"},{"issue":"5","key":"9078_CR239","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1136\/jmg.2010.085456","volume":"48","author":"E Sieni","year":"2011","unstructured":"Sieni E, Cetica V, Santoro A, Beutel K, Mastrodicasa E, Meeths M, Ciambotti B, Brugnolo F, Zur Stadt U, Pende D (2011) Genotype\u2013phenotype study of familial haemophagocytic lymphohistiocytosis type 3. J Med Genet 48(5):343\u2013352","journal-title":"J Med Genet"},{"issue":"8","key":"9078_CR240","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.it.2021.06.001","volume":"42","author":"R Karki","year":"2021","unstructured":"Karki R, Kanneganti T-D (2021) The \u2018cytokine storm\u2019: molecular mechanisms and therapeutic prospects. Trends Immunol 42(8):681\u2013705","journal-title":"Trends Immunol"},{"issue":"12","key":"9078_CR241","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/j.tins.2022.10.007","volume":"45","author":"O Kann","year":"2022","unstructured":"Kann O, Almouhanna F, Chausse B (2022) Interferon \u03b3: a master cytokine in microglia-mediated neural network dysfunction and neurodegeneration. Trends Neurosci 45(12):913\u2013927","journal-title":"Trends Neurosci"},{"issue":"5","key":"9078_CR242","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1212\/WNL.57.5.845","volume":"57","author":"SA Brod","year":"2001","unstructured":"Brod SA, Lindsey J, Vriesendorp F, Ahn C, Henninger E, Narayana P, Wolinsky J (2001) Ingested IFN-\u03b1: results of a pilot study in relapsing-remitting MS. Neurology 57(5):845\u2013852","journal-title":"Neurology"},{"issue":"1","key":"9078_CR243","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/imr.12721","volume":"287","author":"N Mitsuiki","year":"2019","unstructured":"Mitsuiki N, Schwab C, Grimbacher B (2019) What did we learn from CTLA-4 insufficiency on the human immune system? Immunol Rev 287(1):33\u201349","journal-title":"Immunol Rev"},{"issue":"4","key":"9078_CR244","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.bj.2021.04.005","volume":"44","author":"L G\u00e1mez-D\u00edaz","year":"2021","unstructured":"G\u00e1mez-D\u00edaz L, Grimbacher B (2021) Immune checkpoint deficiencies and autoimmune lymphoproliferative syndromes. Biomedical Journal 44(4):400\u2013411","journal-title":"Biomedical Journal"},{"issue":"15","key":"9078_CR245","doi-asserted-by":"publisher","first-page":"e1560","DOI":"10.1212\/WNL.0000000000207609","volume":"101","author":"C Coustal","year":"2023","unstructured":"Coustal C, Goulabchand R, Labauge P, Guilpain P, Carra-Dalli\u00e8re C, Januel E, Jeziorski E, Salle V, Viallard J-F, Boutboul D (2023) Clinical, radiologic, and immunologic features of patients with CTLA4 deficiency with neurologic involvement. Neurology 101(15):e1560\u2013e1566","journal-title":"Neurology"},{"issue":"10","key":"9078_CR246","doi-asserted-by":"publisher","first-page":"5551","DOI":"10.1172\/JCI135947","volume":"130","author":"MK Schindler","year":"2020","unstructured":"Schindler MK, Pittaluga S, Enose-Akahata Y, Su HC, Rao VK, Rump A, Jacobson S, Cortese I, Reich DS, Uzel G (2020) Haploinsufficiency of immune checkpoint receptor CTLA4 induces a distinct neuroinflammatory disorder. J Clin Investig 130(10):5551\u20135561","journal-title":"J Clin Investig"},{"issue":"2","key":"9078_CR247","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/j.jaci.2021.04.039","volume":"149","author":"D Egg","year":"2022","unstructured":"Egg D, Rump IC, Mitsuiki N, Rojas-Restrepo J, Maccari M-E, Schwab C, Gabrysch A, Warnatz K, Goldacker S, Pati\u00f1o V (2022) Therapeutic options for CTLA-4 insufficiency. Journal of Allergy and Clinical Immunology 149(2):736\u2013746","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"1","key":"9078_CR248","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41423-021-00742-4","volume":"19","author":"LA Huppert","year":"2022","unstructured":"Huppert LA, Green MD, Kim L, Chow C, Leyfman Y, Daud AI, Lee JC (2022) Tissue-specific Tregs in cancer metastasis: opportunities for precision immunotherapy. Cell Mol Immunol 19(1):33\u201345","journal-title":"Cell Mol Immunol"},{"key":"9078_CR249","doi-asserted-by":"crossref","unstructured":"Gray PE, David C (2023) Inborn errors of immunity and autoimmune disease. J Allergy Clin Immunol Pract 11(6):1602-1622","DOI":"10.1016\/j.jaip.2023.04.018"},{"key":"9078_CR250","doi-asserted-by":"crossref","first-page":"647","DOI":"10.3389\/fimmu.2016.00647","volume":"7","author":"RA Van Schaarenburg","year":"2016","unstructured":"Van Schaarenburg RA, Magro-Checa C, Bakker JA, Teng YO, Bajema IM, Huizinga TW, Steup-Beekman GM, Trouw LA (2016) C1q deficiency and neuropsychiatric systemic lupus erythematosus. Front Immunol 7:647","journal-title":"Front Immunol"},{"key":"9078_CR251","doi-asserted-by":"publisher","unstructured":"Hoffman HM, Kuemmerle-Deschner JB, Goldbach-Mansky R (2019) Cryopyrin-associated periodic syndromes (CAPS). In: Hashkes P, Laxer R, Simon A (eds) Textbook of autoinflammation. Springer, Cham. https:\/\/doi.org\/10.1007\/978-3-319-98605-0_19","DOI":"10.1007\/978-3-319-98605-0_19"},{"key":"9078_CR252","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s11926-011-0165-y","volume":"13","author":"R Goldbach-Mansky","year":"2011","unstructured":"Goldbach-Mansky R (2011) Current status of understanding the pathogenesis and management of patients with NOMID\/CINCA. Curr Rheumatol Rep 13:123\u2013131","journal-title":"Curr Rheumatol Rep"},{"issue":"1","key":"9078_CR253","doi-asserted-by":"publisher","first-page":"49","DOI":"10.21053\/ceo.2021.00920","volume":"15","author":"L Frejo","year":"2022","unstructured":"Frejo L, Lopez-Escamez JA (2022) Cytokines and inflammation in Meniere disease. Clinical Experimental otorhinolaryngology 15(1):49\u201359","journal-title":"Clinical Experimental otorhinolaryngology"},{"issue":"6","key":"9078_CR254","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1056\/NEJMoa055137","volume":"355","author":"R Goldbach-Mansky","year":"2006","unstructured":"Goldbach-Mansky R, Dailey NJ, Canna SW, Gelabert A, Jones J, Rubin BI, Kim HJ, Brewer C, Zalewski C, Wiggs E (2006) Neonatal-onset multisystem inflammatory disease responsive to interleukin-1\u03b2 inhibition. N Engl J Med 355(6):581\u2013592","journal-title":"N Engl J Med"},{"issue":"2","key":"9078_CR255","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1001\/archderm.141.2.248","volume":"141","author":"C Kilcline","year":"2005","unstructured":"Kilcline C, Shinkai K, Bree A, Modica R, Von Scheven E, Frieden IJ (2005) Neonatal-onset multisystem inflammatory disorder: the emerging role of pyrin genes in autoinflammatory diseases. Arch Dermatol 141(2):248\u2013253","journal-title":"Arch Dermatol"},{"key":"9078_CR256","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-020-01778-5","volume":"17","author":"WT O\u2019Brien","year":"2020","unstructured":"O\u2019Brien WT, Pham L, Symons GF, Monif M, Shultz SR, McDonald SJ (2020) The NLRP3 inflammasome in traumatic brain injury: potential as a biomarker and therapeutic target. J Neuroinflammation 17:1\u201312","journal-title":"J Neuroinflammation"},{"issue":"1","key":"9078_CR257","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/ng.3459","volume":"48","author":"Q Zhou","year":"2016","unstructured":"Zhou Q, Wang H, Schwartz DM, Stoffels M, Park YH, Zhang Y, Yang D, Demirkaya E, Takeuchi M, Tsai WL (2016) Loss-of-function mutations in TNFAIP3 leading to A20 haploinsufficiency cause an early-onset autoinflammatory disease. Nat Genet 48(1):67\u201373","journal-title":"Nat Genet"},{"key":"9078_CR258","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/s41590-025-02092-z","volume":"26","author":"H Iyer","year":"2025","unstructured":"Iyer H, Benoist C, Bilbo SD et al (2025) Systems neuroimmunology: current bottlenecks, research priorities and future directions. Nat Immunol 26:325\u2013329. https:\/\/doi.org\/10.1038\/s41590-025-02092-z","journal-title":"Nat Immunol"},{"issue":"10","key":"9078_CR259","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.it.2015.08.008","volume":"36","author":"Y Wu","year":"2015","unstructured":"Wu Y, Dissing-Olesen L, MacVicar BA, Stevens B (2015) Microglia: dynamic mediators of synapse development and plasticity. Trends Immunol 36(10):605\u2013613","journal-title":"Trends Immunol"},{"key":"9078_CR260","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1007\/s12026-015-8718-1","volume":"63","author":"VA Pavlov","year":"2015","unstructured":"Pavlov VA, Tracey KJ (2015) Neural circuitry and immunity. Immunol Res 63:38\u201357","journal-title":"Immunol Res"},{"key":"9078_CR261","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/bs.ai.2017.06.004","volume":"135","author":"J Presumey","year":"2017","unstructured":"Presumey J, Bialas AR, Carroll MC (2017) Complement system in neural synapse elimination in development and disease. Adv Immunol 135:53\u201379","journal-title":"Adv Immunol"},{"issue":"6","key":"9078_CR262","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.4103\/1673-5374.385854","volume":"19","author":"A Huo","year":"2024","unstructured":"Huo A, Wang J, Li Q, Li M, Qi Y, Yin Q, Luo W, Shi J, Cong Q (2024) Molecular mechanisms underlying microglial sensing and phagocytosis in synaptic pruning. Neural Regen Res 19(6):1284\u20131290","journal-title":"Neural Regen Res"},{"issue":"6","key":"9078_CR263","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.tins.2018.03.009","volume":"41","author":"LG Coulthard","year":"2018","unstructured":"Coulthard LG, Hawksworth OA, Woodruff TM (2018) Complement: the emerging architect of the developing brain. Trends Neurosci 41(6):373\u2013384","journal-title":"Trends Neurosci"},{"issue":"17","key":"9078_CR264","doi-asserted-by":"publisher","first-page":"7975","DOI":"10.1073\/pnas.0913449107","volume":"107","author":"Y Chu","year":"2010","unstructured":"Chu Y, Jin X, Parada I, Pesic A, Stevens B, Barres B, Prince DA (2010) Enhanced synaptic connectivity and epilepsy in C1q knockout mice. Proc Natl Acad Sci 107(17):7975\u20137980","journal-title":"Proc Natl Acad Sci"},{"issue":"3","key":"9078_CR265","doi-asserted-by":"publisher","DOI":"10.1002\/wsbm.1545","volume":"14","author":"BM Soteros","year":"2022","unstructured":"Soteros BM, Sia GM (2022) Complement and microglia dependent synapse elimination in brain development. WIREs mechanisms of disease 14(3)","journal-title":"WIREs mechanisms of disease"},{"issue":"11","key":"9078_CR266","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1038\/mp.2017.151","volume":"22","author":"VL Nimgaonkar","year":"2017","unstructured":"Nimgaonkar VL, Prasad KM, Chowdari KV, Severance EG, Yolken RH (2017) The complement system: a gateway to gene\u2013environment interactions in schizophrenia pathogenesis. Mol Psychiatry 22(11):1554\u20131561","journal-title":"Mol Psychiatry"},{"key":"9078_CR267","doi-asserted-by":"publisher","first-page":"573","DOI":"10.3389\/fpsyt.2019.00573","volume":"10","author":"M Druart","year":"2019","unstructured":"Druart M, Le Magueresse C (2019) Emerging roles of complement in psychiatric disorders. Front Psych 10:573","journal-title":"Front Psych"},{"issue":"2","key":"9078_CR268","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.tins.2023.11.010","volume":"47","author":"L Wen","year":"2024","unstructured":"Wen L, Bi D, Shen Y (2024) Complement-mediated synapse loss in Alzheimer\u2019s disease: mechanisms and involvement of risk factors. Trends Neurosci 47(2):135\u2013149","journal-title":"Trends Neurosci"},{"issue":"1","key":"9078_CR269","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/s41392-021-00867-y","volume":"7","author":"X Han","year":"2022","unstructured":"Han X, Xu T, Ding C, Wang D, Yao G, Chen H, Fang Q, Hu G, Sun L (2022) Neuronal NR4A1 deficiency drives complement-coordinated synaptic stripping by microglia in a mouse model of lupus. Signal Transduct Target Ther 7(1):50","journal-title":"Signal Transduct Target Ther"},{"issue":"11","key":"9078_CR270","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.tins.2012.08.001","volume":"35","author":"BM Elmer","year":"2012","unstructured":"Elmer BM, McAllister AK (2012) Major histocompatibility complex class I proteins in brain development and plasticity. Trends Neurosci 35(11):660\u2013670","journal-title":"Trends Neurosci"},{"issue":"4","key":"9078_CR271","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/nn.2764","volume":"14","author":"MW Glynn","year":"2011","unstructured":"Glynn MW, Elmer BM, Garay PA, Liu X-B, Needleman LA, El-Sabeawy F, McAllister AK (2011) MHCI negatively regulates synapse density during the establishment of cortical connections. Nat Neurosci 14(4):442\u2013451","journal-title":"Nat Neurosci"},{"issue":"1","key":"9078_CR272","doi-asserted-by":"publisher","first-page":"6448","DOI":"10.1038\/s41598-023-30054-8","volume":"13","author":"MJ Lazarczyk","year":"2023","unstructured":"Lazarczyk MJ, Eyford BA, Varghese M, Arora H, Munro L, Warda T, Pfeifer CG, Sowa A, Dickstein DR, Rumbell T (2023) The intracellular domain of major histocompatibility class-I proteins is essential for maintaining excitatory spine density and synaptic ultrastructure in the brain. Sci Rep 13(1):6448","journal-title":"Sci Rep"},{"issue":"1","key":"9078_CR273","doi-asserted-by":"publisher","first-page":"3633","DOI":"10.1038\/ncomms4633","volume":"5","author":"C Cebri\u00e1n","year":"2014","unstructured":"Cebri\u00e1n C, Zucca FA, Mauri P, Steinbeck JA, Studer L, Scherzer CR, Kanter E, Budhu S, Mandelbaum J, Vonsattel JP (2014) MHC-I expression renders catecholaminergic neurons susceptible to T-cell-mediated degeneration. Nat Commun 5(1):3633","journal-title":"Nat Commun"},{"issue":"1","key":"9078_CR274","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.neuron.2009.09.044","volume":"64","author":"CJ Shatz","year":"2009","unstructured":"Shatz CJ (2009) MHC class I: an unexpected role in neuronal plasticity. Neuron 64(1):40\u201345","journal-title":"Neuron"},{"issue":"4","key":"9078_CR275","doi-asserted-by":"publisher","first-page":"705","DOI":"10.4103\/1673-5374.322423","volume":"17","author":"J Cornell","year":"2022","unstructured":"Cornell J, Salinas S, Huang H-Y, Zhou M (2022) Microglia regulation of synaptic plasticity and learning and memory. Neural Regen Res 17(4):705\u2013716","journal-title":"Neural Regen Res"},{"issue":"1","key":"9078_CR276","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/s41467-023-44556-6","volume":"15","author":"R Berglund","year":"2024","unstructured":"Berglund R, Cheng Y, Piket E, Adzemovic MZ, Zeitelhofer M, Olsson T, Guerreiro-Cacais AO, Jagodic M (2024) The aging mouse CNS is protected by an autophagy-dependent microglia population promoted by IL-34. Nat Commun 15(1):383","journal-title":"Nat Commun"},{"key":"9078_CR277","doi-asserted-by":"publisher","unstructured":"Saeki K, Pan R, Lee E, Kurotaki D, Ozato K (2024) IRF8 configures enhancer landscape in postnatal microglia and directs microglia specific transcriptional programs. BioRxiv, 2023-06. https:\/\/doi.org\/10.1101\/2023.06.25.546453","DOI":"10.1101\/2023.06.25.546453"},{"issue":"1","key":"9078_CR278","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.immuni.2019.12.004","volume":"52","author":"S Werneburg","year":"2020","unstructured":"Werneburg S, Jung J, Kunjamma RB, Ha S-K, Luciano NJ, Willis CM, Gao G, Biscola NP, Havton LA, Crocker SJ (2020) Targeted complement inhibition at synapses prevents microglial synaptic engulfment and synapse loss in demyelinating disease. Immunity 52(1):167\u2013182 (e167)","journal-title":"Immunity"},{"key":"9078_CR279","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.neuropharm.2014.10.027","volume":"96","author":"A Vezzani","year":"2015","unstructured":"Vezzani A, Viviani B (2015) Neuromodulatory properties of inflammatory cytokines and their impact on neuronal excitability. Neuropharmacology 96:70\u201382","journal-title":"Neuropharmacology"},{"issue":"1","key":"9078_CR280","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3233\/BPL-200109","volume":"7","author":"DP Nemeth","year":"2021","unstructured":"Nemeth DP, Quan N (2021) Modulation of neural networks by interleukin-1. Brain Plasticity 7(1):17\u201332","journal-title":"Brain Plasticity"},{"issue":"10","key":"9078_CR281","doi-asserted-by":"publisher","first-page":"4637","DOI":"10.1073\/pnas.1813562116","volume":"116","author":"T-T Ta","year":"2019","unstructured":"Ta T-T, Dikmen HO, Schilling S, Chausse B, Lewen A, Hollnagel J-O, Kann O (2019) Priming of microglia with IFN-\u03b3 slows neuronal gamma oscillations in situ. Proc Natl Acad Sci 116(10):4637\u20134642","journal-title":"Proc Natl Acad Sci"},{"key":"9078_CR282","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s12016-019-08738-9","volume":"59","author":"M Jamee","year":"2020","unstructured":"Jamee M, Moniri S, Zaki-Dizaji M, Olbrich P, Yazdani R, Jadidi-Niaragh F, Aghamahdi F, Abolhassani H, Condliffe AM, Aghamohammadi A (2020) Clinical, immunological, and genetic features in patients with activated PI3K\u03b4 syndrome (APDS): a systematic review. Clin Rev Allergy Immunol 59:323\u2013333","journal-title":"Clin Rev Allergy Immunol"},{"key":"9078_CR283","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13223-020-00420-6","volume":"16","author":"M Ewertowska","year":"2020","unstructured":"Ewertowska M, Grze\u015bk E, Urba\u0144czyk A, D\u0105browska A, B\u0105bol-Pokora K, \u0141\u0119cka M, Ko\u0142tan S (2020) Activated phosphoinositide 3-kinase delta syndrome 1 and 2 (APDS 1 and APDS 2): similarities and differences based on clinical presentation in two boys. Allergy Asthma Clin Immunol 16:1\u20137","journal-title":"Allergy Asthma Clin Immunol"},{"key":"9078_CR284","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2019.109644","volume":"94","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Xiang Z, Jia Y, He X, Wang L, Cui W (2019) The Notch signaling pathway inhibitor Dapt alleviates autism-like behavior, autophagy and dendritic spine density abnormalities in a valproic acid-induced animal model of autism. Prog Neuropsychopharmacol Biol Psychiatry 94","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"9078_CR285","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2021.702872","volume":"9","author":"V Redenbaugh","year":"2021","unstructured":"Redenbaugh V, Coulter T (2021) Disorders related to PI3K\u03b4 hyperactivation: characterizing the clinical and immunological features of activated PI3-kinase delta syndromes. Front Pediatr 9","journal-title":"Front Pediatr"},{"issue":"5","key":"9078_CR286","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1210\/er.2017-00232","volume":"39","author":"M Tajan","year":"2018","unstructured":"Tajan M, Paccoud R, Branka S, Edouard T, Yart A (2018) The RASopathy family: consequences of germline activation of the RAS\/MAPK pathway. Endocr Rev 39(5):676\u2013700","journal-title":"Endocr Rev"},{"issue":"6","key":"9078_CR287","doi-asserted-by":"publisher","first-page":"445","DOI":"10.3109\/08830185.2015.1055331","volume":"34","author":"F Fusco","year":"2015","unstructured":"Fusco F, Pescatore A, Conte MI, Mirabelli P, Paciolla M, Esposito E, Lioi MB, Ursini MV (2015) EDA-ID and IP, two faces of the same coin: how the same IKBKG\/NEMO mutation affecting the NF-\u03baB pathway can cause immunodeficiency and\/or inflammation. Int Rev Immunol 34(6):445\u2013459","journal-title":"Int Rev Immunol"},{"issue":"4","key":"9078_CR288","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/S0092-8674(03)00855-9","volume":"115","author":"J Feldmann","year":"2003","unstructured":"Feldmann J, Callebaut I, Raposo G, Certain S, Bacq D, Dumont C, Lambert N, Ouach\u00e9e-Chardin M, Chedeville G, Tamary H (2003) Munc13-4 is essential for cytolytic granules fusion and is mutated in a form of familial hemophagocytic lymphohistiocytosis (FHL3). Cell 115(4):461\u2013473","journal-title":"Cell"},{"issue":"4","key":"9078_CR289","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.ajhg.2009.09.005","volume":"85","author":"U Zur Stadt","year":"2009","unstructured":"Zur Stadt U, Rohr J, Seifert W, Koch F, Grieve S, Pagel J, Strau\u00df J, Kasper B, N\u00fcrnberg G, Becker C (2009) Familial hemophagocytic lymphohistiocytosis type 5 (FHL-5) is caused by mutations in Munc18-2 and impaired binding to syntaxin 11. Am J Human Genet 85(4):482\u2013492","journal-title":"Am J Human Genet"},{"issue":"12","key":"9078_CR290","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.3324\/haematol.2010.029389","volume":"95","author":"J Rohr","year":"2010","unstructured":"Rohr J, Beutel K, Maul-Pavicic A, Vraetz T, Thiel J, Warnatz K, Bondzio I, Gross-Wieltsch U, Sch\u00fcndeln M, Sch\u00fctz B (2010) Atypical familial hemophagocytic lymphohistiocytosis due to mutations in UNC13D and STXBP2 overlaps with primary immunodeficiency diseases. Haematologica 95(12):2080","journal-title":"Haematologica"},{"issue":"14","key":"9078_CR291","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1093\/hmg\/ddab113","volume":"30","author":"E Ichise","year":"2021","unstructured":"Ichise E, Chiyonobu T, Ishikawa M, Tanaka Y, Shibata M, Tozawa T, Taura Y, Yamashita S, Yoshida M, Morimoto M (2021) Impaired neuronal activity and differential gene expression in STXBP1 encephalopathy patient iPSC-derived GABAergic neurons. Hum Mol Genet 30(14):1337\u20131348","journal-title":"Hum Mol Genet"},{"issue":"15","key":"9078_CR292","first-page":"2635","volume":"116","author":"M Meeths","year":"2010","unstructured":"Meeths M, Entesarian M, Al-Herz W, Chiang SC, Wood SM, Al-Ateeqi W, Almazan F, Boelens JJ, Hasle H, Ifversen M (2010) Spectrum of clinical presentations in familial hemophagocytic lymphohistiocytosis type 5 patients with mutations in STXBP2. Blood, J AmSociety of Hematology 116(15):2635\u20132643","journal-title":"Blood, J AmSociety of Hematology"},{"issue":"1","key":"9078_CR293","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s12016-021-08916-8","volume":"63","author":"E Perez","year":"2022","unstructured":"Perez E (2022) Future of therapy for inborn errors of immunity. Clin Rev Allergy Immunol 63(1):75\u201389","journal-title":"Clin Rev Allergy Immunol"},{"issue":"1","key":"9078_CR294","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/s41572-018-0027-2","volume":"4","author":"BC Kieseier","year":"2018","unstructured":"Kieseier BC, Mathey EK, Sommer C, Hartung H-P (2018) Immune-mediated neuropathies. Nat Rev Dis Prim 4(1):31","journal-title":"Nat Rev Dis Prim"},{"key":"9078_CR295","doi-asserted-by":"crossref","unstructured":"Tsang E, Han VX, Flutter C, Alshammery S, Keating BA, Williams T, Gloss BS, Graham ME, Aryamanesh N, Pang I (2024) Ketogenic diet modifies ribosomal protein dysregulation in KMT2D Kabuki syndrome. EBioMedicine 104:105156","DOI":"10.1016\/j.ebiom.2024.105156"},{"issue":"10","key":"9078_CR296","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1016\/j.clinthera.2019.07.009","volume":"41","author":"Y Chen","year":"2019","unstructured":"Chen Y, Wang C, Xu F, Ming F, Zhang H (2019) Efficacy and tolerability of intravenous immunoglobulin and subcutaneous immunoglobulin in neurologic diseases. Clin Ther 41(10):2112\u20132136","journal-title":"Clin Ther"},{"issue":"2","key":"9078_CR297","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/s41409-019-0684-0","volume":"55","author":"B Sharrack","year":"2020","unstructured":"Sharrack B, Saccardi R, Alexander T, Badoglio M, Burman J, Farge D, Greco R, Jessop H, Kazmi M, Kirgizov K (2020) Autologous haematopoietic stem cell transplantation and other cellular therapy in multiple sclerosis and immune-mediated neurological diseases: updated guidelines and recommendations from the EBMT Autoimmune Diseases Working Party (ADWP) and the Joint Accreditation Committee of EBMT and ISCT (JACIE). Bone Marrow Transplant 55(2):283\u2013306","journal-title":"Bone Marrow Transplant"},{"issue":"9","key":"9078_CR298","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.27263","volume":"65","author":"ML Hulbert","year":"2018","unstructured":"Hulbert ML, Shenoy S (2018) Hematopoietic stem cell transplantation for sickle cell disease: progress and challenges. Pediatr Blood Cancer 65(9)","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"9078_CR299","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2020.101515","volume":"34","author":"G Griffin","year":"2020","unstructured":"Griffin G, Shenoi S, Hughes GC (2020) Hemophagocytic lymphohistiocytosis: an update on pathogenesis, diagnosis, and therapy. Best Pract Res Clin Rheumatol 34(4)","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"9078_CR300","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1162605","volume":"14","author":"M Slatter","year":"2023","unstructured":"Slatter M, Lum SH (2023) Personalized hematopoietic stem cell transplantation for inborn errors of immunity. Front Immunol 14","journal-title":"Front Immunol"},{"key":"9078_CR301","doi-asserted-by":"crossref","unstructured":"Burt RK, Sharrack B, Burman J, Nelson F, Rose J, Han X, Quigley K, Saccardi R (2021) Autologous hematopoietic stem cell transplantation for relapsing-remitting multiple sclerosis. In: Hematopoietic stem cell transplantation and cellular therapies for autoimmune diseases. CRC Press, pp 375\u2013385","DOI":"10.1201\/9781315151366-41"},{"issue":"3","key":"9078_CR302","doi-asserted-by":"publisher","first-page":"e00035-19","DOI":"10.1128\/CMR.00035-19","volume":"33","author":"JS Davis","year":"2020","unstructured":"Davis JS, Ferreira D, Paige E, Gedye C, Boyle M (2020) Infectious complications of biological and small molecule targeted immunomodulatory therapies. Clin Microbiol Rev 33(3):e00035-19. https:\/\/doi.org\/10.1128\/cmr","journal-title":"Clin Microbiol Rev"},{"issue":"11","key":"9078_CR303","doi-asserted-by":"publisher","first-page":"3243","DOI":"10.1016\/j.ymthe.2021.09.003","volume":"29","author":"A Pickar-Oliver","year":"2021","unstructured":"Pickar-Oliver A, Gough V, Bohning JD, Liu S, Robinson-Hamm JN, Daniels H, Majoros WH, Devlin G, Asokan A, Gersbach CA (2021) Full-length dystrophin restoration via targeted exon integration by AAV-CRISPR in a humanized mouse model of Duchenne muscular dystrophy. Mol Ther 29(11):3243\u20133257","journal-title":"Mol Ther"},{"issue":"4","key":"9078_CR304","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.molmed.2016.02.002","volume":"22","author":"C Booth","year":"2016","unstructured":"Booth C, Gaspar HB, Thrasher AJ (2016) Treating immunodeficiency through HSC gene therapy. Trends Mol Med 22(4):317\u2013327","journal-title":"Trends Mol Med"},{"issue":"20","key":"9078_CR305","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1182\/bloodadvances.2017010835","volume":"1","author":"CC Dvorak","year":"2017","unstructured":"Dvorak CC, Puck JM, Wahlstrom JT, Dorsey M, Melton A, Cowan MJ (2017) Neurologic event\u2013free survival demonstrates a benefit for SCID patients diagnosed by newborn screening. Blood Adv 1(20):1694\u20131698","journal-title":"Blood Adv"},{"issue":"2","key":"9078_CR306","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.ymthe.2020.11.020","volume":"29","author":"F Tucci","year":"2021","unstructured":"Tucci F, Scaramuzza S, Aiuti A, Mortellaro A (2021) Update on clinical ex vivo hematopoietic stem cell gene therapy for inherited monogenic diseases. Mol Ther 29(2):489\u2013504","journal-title":"Mol Ther"},{"issue":"4","key":"9078_CR307","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1158\/2643-3230.BCD-23-0272","volume":"5","author":"M Abou-el-Enein","year":"2024","unstructured":"Abou-el-Enein M (2024) The fate (s) of CAR T-cell therapy: navigating the risks of CAR+ T-cell malignancy. Blood Cancer Discov 5(4):249\u2013257","journal-title":"Blood Cancer Discov"},{"key":"9078_CR308","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/B978-0-443-23841-3.00013-3","volume-title":"Targeted Therapy for the Central Nervous System","author":"R Patel","year":"2025","unstructured":"Patel R, Patel J (2025) Immunosuppressive and immunomodulatory therapies. Targeted Therapy for the Central Nervous System. Elsevier, edn, pp 285\u2013300"},{"key":"9078_CR309","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1002\/9781683674023.ch68","volume":"2","author":"S Chandrakasan","year":"2024","unstructured":"Chandrakasan S, Uzel G, Lucas CL, Snow AL (2024) Primary immune regulatory disorders. Man Mol Clin Lab Immunol 2:732\u2013751","journal-title":"Man Mol Clin Lab Immunol"},{"key":"9078_CR310","doi-asserted-by":"publisher","DOI":"10.3389\/fopht.2024.1337329","volume":"4","author":"A Fonollosa","year":"2024","unstructured":"Fonollosa A, Carre\u00f1o E, Vitale A, Jindal AK, Ramanan AV, Pelegr\u00edn L, Santos-Zorrozua B, G\u00f3mez-Caverzaschi V, Cantarini L, Fabiani C (2024) Update on ocular manifestations of the main monogenic and polygenic autoinflammatory diseases. Front Ophthalmol 4","journal-title":"Front Ophthalmol"},{"issue":"1","key":"9078_CR311","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1186\/s12974-024-03212-6","volume":"21","author":"V Schiel","year":"2024","unstructured":"Schiel V, Bhattacharya R, Gupta A, Eftekharian K, Xia A, Santa Maria PL (2024) Targeting the NLRP3 inflammasome in cochlear macrophages protects against hearing loss in chronic suppurative otitis media. J Neuroinflammation 21(1):223","journal-title":"J Neuroinflammation"},{"key":"9078_CR312","doi-asserted-by":"publisher","unstructured":"Xu Y, Chen J, Zhou H (2024) Antibody-based biotherapeutics in inflammatory diseases. In:\u00a0Crommelin DJA, Sindelar RD,\u00a0Meibohm B (eds)\u00a0Pharmaceutical biotechnology. Springer, Cham. https:\/\/doi.org\/10.1007\/978-3-031-30023-3_24","DOI":"10.1007\/978-3-031-30023-3_24"},{"issue":"5","key":"9078_CR313","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1038\/s41583-024-00805-1","volume":"25","author":"T Ravizza","year":"2024","unstructured":"Ravizza T, Scheper M, Di Sapia R, Gorter J, Aronica E, Vezzani A (2024) mTOR and neuroinflammation in epilepsy: implications for disease progression and treatment. Nat Rev Neurosci 25(5):334\u2013350","journal-title":"Nat Rev Neurosci"},{"issue":"1","key":"9078_CR314","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1146\/annurev-immunol-082323-124920","volume":"43","author":"MJ Bender","year":"2025","unstructured":"Bender MJ, Lucas CL (2025) Decoding immunobiology through genetic errors of immunity. Annual Annu Rev Immunol 43(1):285\u2013311","journal-title":"Annual Annu Rev Immunol"},{"key":"9078_CR315","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1038\/s41375-025-02569-8","volume":"39","author":"F Perner","year":"2025","unstructured":"Perner F, Pahl HL, Zeiser R et al (2025) Malignant JAK-signaling: at the interface of inflammation and malignant transformation. Leukemia 39:1011\u20131030. https:\/\/doi.org\/10.1038\/s41375-025-02569-8","journal-title":"Leukemia"},{"issue":"1","key":"9078_CR316","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1080\/14728214.2024.2445508","volume":"30","author":"D Politano","year":"2025","unstructured":"Politano D, Tonduti D, Battini R, Fazzi E, Orcesi S (2025) Exploring emerging JAK inhibitors in the treatment of Aicardi-Gouti\u00e8res syndrome. Expert Opin Emerg Drugs 30(1):21\u201339","journal-title":"Expert Opin Emerg Drugs"},{"key":"9078_CR317","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.717388","volume":"12","author":"J Hadjadj","year":"2021","unstructured":"Hadjadj J, Fr\u00e9mond M-L, Neven B (2021) Emerging place of JAK inhibitors in the treatment of inborn errors of immunity. Front Immunol 12","journal-title":"Front Immunol"},{"issue":"1","key":"9078_CR318","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1111\/imr.13312","volume":"322","author":"NS Chaimowitz","year":"2024","unstructured":"Chaimowitz NS, Smith MR, Forbes Satter LR (2024) JAK\/STAT defects and immune dysregulation, and guiding therapeutic choices. Immunol Rev 322(1):311\u2013328","journal-title":"Immunol Rev"},{"issue":"1","key":"9078_CR319","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.autrev.2012.07.020","volume":"12","author":"L Cantarini","year":"2012","unstructured":"Cantarini L, Lucherini OM, Muscari I, Frediani B, Galeazzi M, Brizi MG, Simonini G, Cimaz R (2012) Tumour necrosis factor receptor-associated periodic syndrome (TRAPS): state of the art and future perspectives. Autoimmun Rev 12(1):38\u201343","journal-title":"Autoimmun Rev"},{"issue":"14","key":"9078_CR320","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1056\/NEJM200010053431412","volume":"343","author":"E Drewe","year":"2000","unstructured":"Drewe E, McDermott EM, Powell RJ (2000) Treatment of the nephrotic syndrome with etanercept in patients with the tumor necrosis factor receptor\u2013associated periodic syndrome. N Engl J Med 343(14):1044\u20131045","journal-title":"N Engl J Med"},{"key":"9078_CR321","doi-asserted-by":"publisher","first-page":"1255533","DOI":"10.3389\/fimmu.2023.1255533","volume":"14","author":"E Grebenciucova","year":"2023","unstructured":"Grebenciucova E, VanHaerents S (2023) Interleukin 6: at the interface of human health and disease. Front Immunol 14:1255533","journal-title":"Front Immunol"},{"issue":"1","key":"9078_CR322","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/nrd.2017.162","volume":"17","author":"SH Kaufmann","year":"2018","unstructured":"Kaufmann SH, Dorhoi A, Hotchkiss RS, Bartenschlager R (2018) Host-directed therapies for bacterial and viral infections. Nat Rev Drug Discovery 17(1):35\u201356","journal-title":"Nat Rev Drug Discovery"},{"issue":"6","key":"9078_CR323","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1111\/j.1468-1331.2009.02600.x","volume":"16","author":"I Russo","year":"2009","unstructured":"Russo I, Cosentino C, Del Giudice E, Broccoletti T, Amorosi S, Cirillo E, Aloj G, Fusco A, Costanzo V, Pignata C (2009) In ataxia-teleangiectasia betamethasone response is inversely correlated to cerebellar atrophy and directly to antioxidative capacity. Eur J Neurol 16(6):755\u2013759","journal-title":"Eur J Neurol"},{"issue":"4","key":"9078_CR324","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1111\/j.1468-1331.2010.03203.x","volume":"18","author":"T Broccoletti","year":"2011","unstructured":"Broccoletti T, Del Giudice E, Cirillo E, Vigliano I, Giardino G, Ginocchio V, Bruscoli S, Riccardi C, Pignata C (2011) Efficacy of very-low-dose betamethasone on neurological symptoms in ataxia-telangiectasia. Eur J Neurol 18(4):564\u2013570","journal-title":"Eur J Neurol"},{"issue":"4","key":"9078_CR325","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1002\/med.21458","volume":"38","author":"R Bansal","year":"2018","unstructured":"Bansal R, Singh R (2018) Exploring the potential of natural and synthetic neuroprotective steroids against neurodegenerative disorders: a literature review. Med Res Rev 38(4):1126\u20131158","journal-title":"Med Res Rev"},{"key":"9078_CR326","doi-asserted-by":"crossref","unstructured":"Lai J, Demirbas D, Kim J, Jeffries AM, Tolles A, Park J, Chittenden TW, Buckley PG, Yu TW, Lodato MA, Lee EA\u00a0(2024) ATM-deficiency-induced microglial activation promotes neurodegeneration in ataxia-telangiectasia. Cell Rep 43(1):113622","DOI":"10.1016\/j.celrep.2023.113622"},{"issue":"5","key":"9078_CR327","doi-asserted-by":"publisher","first-page":"2700","DOI":"10.1093\/nar\/gkac104","volume":"50","author":"J Bourseguin","year":"2022","unstructured":"Bourseguin J, Cheng W, Talbot E, Hardy L, Lai J, Jeffries AM, Lodato MA, Lee EA, Khoronenkova SV (2022) Persistent DNA damage associated with ATM kinase deficiency promotes microglial dysfunction. Nucleic Acids Res 50(5):2700\u20132718","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"9078_CR328","first-page":"109","volume":"26","author":"H Quek","year":"2017","unstructured":"Quek H, Luff J, Cheung K, Kozlov S, Gatei M, Lee CS, Bellingham MC, Noakes PG, Lim YC, Barnett NL (2017) A rat model of ataxia-telangiectasia: evidence for a neurodegenerative phenotype. Hum Mol Genet 26(1):109\u2013123","journal-title":"Hum Mol Genet"},{"issue":"9","key":"9078_CR329","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/S1474-4422(24)00220-5","volume":"23","author":"S Zielen","year":"2024","unstructured":"Zielen S, Crawford T, Benatti L, Magnani M, Kieslich M, Ryan M, Meyts I, Gulati S, Borgohain R, Yadav R (2024) Safety and efficacy of intra-erythrocyte dexamethasone sodium phosphate in children with ataxia telangiectasia (ATTeST): a multicentre, randomised, double-blind, placebo-controlled phase 3 trial. Lancet Neurol 23(9):871\u2013882","journal-title":"Lancet Neurol"},{"issue":"2","key":"9078_CR330","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.tmrv.2017.09.001","volume":"32","author":"SA Coker","year":"2018","unstructured":"Coker SA, Szczepiorkowski ZM, Siegel AH, Ferrari A, Mambrini G, Anand R, Hartman RD, Benatti L, Dumont LJ (2018) A study of the pharmacokinetic properties and the in vivo kinetics of erythrocytes loaded with dexamethasone sodium phosphate in healthy volunteers. Transfus Med Rev 32(2):102\u2013110","journal-title":"Transfus Med Rev"},{"key":"9078_CR331","doi-asserted-by":"publisher","unstructured":"McDonald\u2010McGinn DM, Jeong S, McGinn MJ, Zackai EH, Unolt M (2021) Deletion 22q11. 2 (velo\u2010cardio\u2010facial syndrome\/DiGeorge syndrome). Cassidy and Allanson's Management of Genetic Syndromes 291\u2013316.\u00a0https:\/\/doi.org\/10.1002\/9781119432692.ch21","DOI":"10.1002\/9781119432692.ch21"},{"issue":"1","key":"9078_CR332","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1111\/imr.13297","volume":"322","author":"G Bucciol","year":"2024","unstructured":"Bucciol G, Delafontaine S, Meyts I, Poli C (2024) Inborn errors of immunity: a field without frontiers. Immunol Rev 322(1):15\u201327","journal-title":"Immunol Rev"},{"issue":"7","key":"9078_CR333","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1007\/s40265-022-01717-z","volume":"82","author":"SU Rawal","year":"2022","unstructured":"Rawal SU, Patel BM, Patel MM (2022) New drug delivery systems developed for brain targeting. Drugs 82(7):749\u2013792","journal-title":"Drugs"},{"issue":"2","key":"9078_CR334","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/nrn2559","volume":"10","author":"PJ McKinnon","year":"2009","unstructured":"McKinnon PJ (2009) DNA repair deficiency and neurological disease. Nat Rev Neurosci 10(2):100\u2013112","journal-title":"Nat Rev Neurosci"},{"key":"9078_CR335","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s40265-018-1046-8","volume":"79","author":"ZT Al-Salama","year":"2019","unstructured":"Al-Salama ZT (2019) Emapalumab: first global approval. Drugs 79:99\u2013103","journal-title":"Drugs"},{"key":"9078_CR336","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/s41586-024-08487-6","volume":"639","author":"SP Pa\u0219ca","year":"2024","unstructured":"Pa\u0219ca SP, Arlotta P, Bateup HS et al (2024) A framework for neural organoids, assembloids and transplantation studies. Nature 639:315\u2013320. https:\/\/doi.org\/10.1038\/s41586-024-08487-6","journal-title":"Nature"},{"key":"9078_CR337","doi-asserted-by":"crossref","unstructured":"Summers RA, Fagiani F, Rowitch DH, Absinta M, Reich DS (2024) Novel human iPSC models of neuroinflammation in neurodegenerative disease and regenerative medicine. Trends Immunol 45(10):799-813","DOI":"10.1016\/j.it.2024.08.004"},{"issue":"4","key":"9078_CR338","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1001\/jamaneurol.2022.5332","volume":"80","author":"S Dybowski","year":"2023","unstructured":"Dybowski S, Torke S, Weber MS (2023) Targeting B cells and microglia in multiple sclerosis with Bruton tyrosine kinase inhibitors: a review. JAMA Neurol 80(4):404\u2013414","journal-title":"JAMA Neurol"},{"issue":"5","key":"9078_CR339","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/s41577-023-00960-z","volume":"24","author":"A Liston","year":"2024","unstructured":"Liston A, Pasciuto E, Fitzgerald DC, Yshii L (2024) Brain regulatory T cells. Nat Rev Immunol 24(5):326\u2013337","journal-title":"Nat Rev Immunol"},{"issue":"8","key":"9078_CR340","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/s41583-024-00829-7","volume":"25","author":"J Gao","year":"2024","unstructured":"Gao J, Gunasekar S, Xia Z, Shalin K, Jiang C, Chen H, Lee D, Lee S, Pisal ND, Luo JN (2024) Gene therapy for CNS disorders: modalities, delivery and translational challenges. Nat Rev Neurosci 25(8):553\u2013572","journal-title":"Nat Rev Neurosci"}],"container-title":["Clinical Reviews in Allergy &amp; Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-025-09078-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12016-025-09078-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-025-09078-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T14:26:03Z","timestamp":1757255163000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12016-025-09078-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,18]]},"references-count":340,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["9078"],"URL":"https:\/\/doi.org\/10.1007\/s12016-025-09078-7","relation":{},"ISSN":["1559-0267"],"issn-type":[{"value":"1559-0267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,18]]},"assertion":[{"value":"27 June 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval Statement"}},{"value":"Not appliable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient Consent Statement"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Institutional Review Board Statement"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent Statement"}}],"article-number":"67"}}